Note: Descriptions are shown in the official language in which they were submitted.
~3~
~ rhere is continuing interest in d~veloping new, -
simpler and more rapid techniques t~ méasllre the presence of
an analyte in a sa:mple su~pected ~ of containing an analyte .
The analyte may be any of a wide ~ariety of materials, such
as drugs, naturally occurring physiological compo~mcls, pol~
lutant~, fine chemicals, contaminants, or the like. In many
cases, ~peed is important for the measurement, particularly
with certain physiologically active compounds. In other
situations, convenience can be a major consideration.
One convenient techni~ue which has found wide
application i~ the use of a "dip ~tick." ~aving a solid rod
or film which can be dipped in a sample and ~hen sub~Pquently
processed to produce a siynal based on the ~amount of a~alyte
in the original sample can provide many conveniences. There
is ample instrumentation to measure a signal, ~uch as l:ight
absorptio~ or fluorescence, ~f a compound bound to a solid
~urface. Al~o, the dip sticlc allows for convenient handling,
transfers/ 6eparations, and the like.
In developing an assay, it is desirable that ~here
~e a minimum nu~ber of steps and transfers in performing the
~ssay, as well as a minimum numbe~ of separate .reagents.
Therefore, while a dip ~tick add~ a convenience to ~epara-
~ions, the separation~ in themselves are unde~irable. Fur-
~ermore / the fewer the reagents that have to be pacXaged,
30 added, and formulated, the fewer the errors which will be
introduced into the assay and the grea ter economies and
con~renience of the as~ay .
.
. . ..
:. '
~ - :
`3~
It is therefore desirable to develop new assay
methods, particularly employing rigid solid surfaces which
may ox may not be separated from the assay medium for mea-
surement, where the signal may be develop~d without concern
as to the presence o reagents in the solution affecting the
observed signal on the solid surfaceO
Patents concerned with various immobiliY.ed reagents
in different types of test strips include U.S. Patent Nos.
3,993,451; 4,038,485; 4,046,514; 4,129j417; 4,133,639; and
4,16Q,008, and Ger. Offen. 2,636,244. Patènts disclosing a
variety of methods involving separations of bound and unbound
antigen include U.S. Patent Nos. Re. 29,169j 3,9497064;
3,984,533;. 3,985,867; 4,020,151; 4,~9,652; 4,067,959 ;
4,108,972; 4,145,406, and 4,168,14~ . `
( Patents of particular interest)
A method is provided employing a relatively rigid
insoluble, preferably bibulous, surface to which is ~onjugat-
ed a member of an immunological pair.(abbreviated as "mip")the immunological pair consisting of ligand and a receptor
which specifically binds to khe ligand or their functional
equivalent for the purposes of this invention. .In addition
to the surface, a signal producing system is provided which
has as one member a catalyst, norm~lly an enæyme, which is
conjuyated to a mip~ Depending upon the amount of analyte
present, the c~talyst labeled mip will be partitioned between
the bulk solution of the assay medium and the surface. The
signal producing system provides a signal generating compound
at the surface which generates a signal which is not signifi-
cantly affected by any signal generating compound produced or
present in the bulk solution. Therefore, the signal qenerat-
ing compound may be generated in the assay medium in the
presence o~ unbound catalyst labeled mip. When the only
catalyst in the ~i~nal producing system is khe catalyst-
labeled-mip, ~ar.ious expedienks can be employed to enhance
the difference in ~he rate of formation of the signal gener-
ating compound at the surface as compared to the bulk solu
. :.
,: ..
. , . :
933~
tion, e.g. enhancing the catalyst turnover rate at the
surface. In addition to enhance the simplicity of this
protocol, the last of the components of the signal generating
system will be added at about the time of or before the
addition of the catalyst bound to the mip.
Compositions are provided for performlng the assay
comprising combinations of the surface and various reagents
in relative amounts ~or optimizing the sensitivity and accu-
racy of the assay.
The subject assay provides for a convenient method
for detecting and measuring a wide variety of analytes in a
si~ple, efficient, reproducible manner, w~ich can employ
visual inspection or conventional e~uipment for measuring a
spectrophotometric propert~ of a product bound to a sur~ace.
In accordance with the subject invention, an assay
method and compositions are provided for measuring a wide
variety of analytes, where the analyte is a member of an
immunological pair (mip), the pair consisting of a ligand and
a receptor (antiligand) which specifically binds to the
ligand,or their functional equivalent for the purposes of the
assay. The assay method has two e~sential elements: a
surface to which is conjugated a mip; and a ~ignal producing
system which results in a si~nal generating compound associ-
ated with the surface, producing a detectible signal-in an
~nount related to the amount of analyte in the assay medium.
Preferably, the signal producing system will effect a two or
more step conversion involving one or more compounds to
pxoduce, block or de~troy the signal generating compound,
where the rate of change in the concentration of the signal
generating compound is related to the avPrage distance
between two molecules on the surface. The molecules may be
the same or different. The immunological binding at the
surface allows for localized enhanced concentrations of
compounds o the ~ignal producing system at the suxface.
Also, one may employ a scavenger as a third component which
acts to inhibit the operation at the signal producing system
in the bulk solution by scavenging an intermediate, catalyst
or signal generating compound in the bulk solution.
`' '
32
The surface may be any convenient structure which
substantially retains its form and may ~e separable from or
part of the container. The manner of binding o.f the mip to
the surface is not a critical aspect of this invention, so
long as a sufficien-t amount of the mip is exposed to allow
for binding to its homologous partner.
The signal producing system has at leas-t two mem~
bers: A catalyst, normally an enzyme, conjugated to a mip;
and a solute which underyoes a reaction with a substance
bound to thè surface, and thereby directly or indirectly
enhances or inhibits the production of a detectible signal.
The association of a member of the -signal producing system
with the surface may be as a result of insolubilization,
complexation with a compound on the surface or interaction,
including reaction, with a compound on the surface.
Where an intermediate material is produced by the
signal producing system in sol~le form, both in the bulk
solution and at the surface, a scavenger can advantageously
be employed, so as to substantially minimize the interaction
of the intermediate material produced in ~he bulk solution
with the surface.
A wide variety of different systems may be employed
for altering the degree of production of the product at the
surface as compared to the bulk solution and fox inhibiting
intermediates or product produced in or migratiny into the
bulk solution from interacting with the surface. Depending
upon the particular pxotocols, various additions, incubation
steps, and reagents will be employed.
By providiny for the production of a detectible
signal generatin~ material on the surface that is related to
the amount of analy~e in a sample, one can relate the signal
level detected from the surface to the amount of analyte in
the solution. By employing standards having known amounts of
analyte under the same ox substantially the same conditions
as with an unknown, one can quantitate the detected signal
level with the amount of analyte in the sample.
In accordance with the subject invention, the
method is performed wi~hout regu.iring a separation of bound
,
and unbound catalyst-bound mip, nor requiring a separation of
analyte from the remainder of the sample, although the latter
may be desirable. This provides substantial advantages in
the convenience of the protocol and in avoiding the diffi~
culties in achieving a clean separation.
The subject invention achieves a precise, specific
and sensitive techni~ue for detecting and measuring ligands
and ligand receptors. The method provides for the preferen-
tial production, i~hibition of production or destruction of a
compound at a rigid surface, which compound is involved with
the generation of a signal at the surface. The signal gener-
ating compound associ~ted with the surface will be of a
sufficient depth on or in the surface to provide a measurable
signal.
For a large number of analytes, the concentration
range of interest will fall between 100~g to one pg per ml.
For many analytes, the concentration range of interest will
vary from about two-fold to 100-fold so that a quantitative
determination will require the ability to distinguish small
~0 differences in the concen-tration of the analyte in the assay
medium. Immunoas~ays are predicated on detecting the com-
plexation between ligand and receptor, where one or both may
be labeled. The lower the concentration of the analyte, the
fewer the number of complexes which are formed. Therefore,
in order to be able to accurately-determine the number of
labeled complexes which are formed, either the label must
provide a siynal which can be efficiently counted at an
extremely low level of events, e.g. radioactive emission, or
the complex must permit amplification or multiplication, e.g.
fluores~ence ox a catalyzed reaction.
When employing ~n amplification system, many prob-
lems are encountered. One serious problem is signal result-
ing from other than labeled complexes, namely background.
Background signal can result from materials in ~he sample;
labeled contaminants when labeling the member of -~he immuno-
logical pair, and un~ound labeled member. In developing an
assay, the signal generated by labeled complexes must not be
obscured by the signal from the background and must be sub-
~3~3~
stantially greater than the ~ackground signal. Therefore any
amplification achieved by the signal generating system must
be primarily, if not solely, associated wi~h the labeled
comple~ rather than with background label.
In many assay techni~ues a clean separation of
labeled immune complex and bac~ground label is re~uired,
where careful attention must be given to non-specific ef-
fects~ For example, where a fluorescent label is employed in
a heterogeneous system, e.g. dipstick, after combining all of
the reagents with the dipstick, the dipstick must be removed
and carefully washed to remove any fluorescer which is non~
specifically bound. Furthermore, the number of fluorescers
involved with a complex is limited to the nu~ber which can be
conveniently conjugated to a member of an immunolo~ical pair,
although further amplification can be obtained by employing a
second labeled receptox which binds to a first receptor which
binds to a ligand analyte. This step re~uires an additional
reagent, another addition and a careful separation to avoid
non-specific interastions.
The subject invention obviates or minimizes many of
the shortsomings of other methods. For each complex a plu-
rality of signal generating events are achieved by employing
a catalyst. The catalyst is partitioned between ~he bulk
solution and a surface i~ proportion to the ~nount of analyte
in the assay medium. The production of signal generating
product resulting from the catalyzed reaction at the surface
is substantially independent of concurrent production of
signal generating pro~uct, if any, produced in the bulk
solution. Thus, the assay operates with the catalyst present
in the bulk solution during the time the modulation of the
amount of signal generating compound at the surface is occur-
ring. The need for separating the surface from the bulk
solution, whether careful or not, for measuring the si~nal is
avoided in the subject invention, although the separation may
be preferable.
Furthermore, in the subject inv ntion, ~he siynal
generating compound can ~e of suhstantial depth on or in the
surface. The presence of the catalyst at the surface allows
3~33~:
for the deposition ox conversion of a large number of signal
generating compounds to provide a strong sic~al. This is of
great importance when the measurement is vi~:ual inspection,
particularly where the signal generation involves the absorp-
tion o light.
Before ~urther describing the invention, a number
of terms will be defined.
DEFINITIONS
Analyte - the compound or composit:ion to be mea
sured, which may be a ligand, which is mono or polyepitopic,
usually antigenic or haptenic, a single or plurality of
compounds which share at least one common epitopic or deter-
minant site or a recep~or.
Specific binding pair - two diferent molecules,'
where one of the molecules has an area on the su'rface or in a
cavity which specifically binds to a particular spatial and
polar organization of the other molecule. The members of the
specific binding pair are referred to as ligand and receptor
(antiliyand~. These will be referred ~o in the subject
application as members of an immunological pair, abbreviated
as "mip". ~omologous or complementary mips are ligand and
receptor, while analogous mips are either ligands or recep-
tors, which are differentiated in some mar~er, e.g. labeling.
Li~and ~ any organic compound for which a receptor
naturally exists or can be prepared~
Receptor (antiligand) - any compound or composition
capable of recognizing a particular spatial and polar organ-
ization of a molecule i.e. epitopic or determinant site.
Illustrative receptors include naturally occurring receptors,
e.g. -thyroxine binding globulin, antibodies, enzymes, Fab
fragments, lectins, nucleic acids and -the like.
Ligand Analog - a modified ligand which can compete
wi~h the analogous ligand for a receptor, the modification
providing means to join a ligand analog to another molecule.
The ligand analog will usually differ from the ligand by more
than replacement of a hydrogen with a bond which links ~he
ligand analog to 2 hub or label, but need not.
: . :.
~f~3~3~
Polytligand-analog3 - a plurality of ligands or
ligand analogs covalently joined together, nQrmally to a hub
nucleus. The hub nucleus is a polyfunctional material,
normally polymeric, usually having a plurality o~ functional
S groups e.g. hydroxy, amino, mercapto, ethylenic, etc. as
sites for linking. The hub nucleus is normally water soluble
or at least dispersible and will usually be at least about
35,000 daltons, but generally not exceeding about 600,000
daltons. Illustrative hub nuclei include polysaccharides,
polypeptides, including proteins, nucleic acids, ion e~change
resins and the like.
Surface - the surface will-be non dispersed ancl of
a dimension of at least about l~m2 and generally greater,
often at least about ln~2, frequently ~from about O.Scm2 to
lOcm2, usually being on a support when less than about
0.5cm2; and may be of any material which is insoluble in
water and provides the necessary properties for binding of a
mip and a detectible signal generating compound ~o provide a
desired signal level. Desirably, the surface will be
gelatinous, permeable, porous or have a rough or irregular
structure, which may include channels or indentation~, gener~
ally having a substantial void volume as compared to total
volume. Dependin~ upon the nature of the detectible signal
generating compound, the surface will be adsorbent or non-
adsorbent, preferably being weakly or non-adsorbent. The
surface may be transparent or opaque, a single material or a
plurality of materials, mixtures or laminates. A wide var-
iety of materials and shapes may be employed. The surface
will be capable of substantially retaining its integrity
under the conditions of ~he assay so that substances which
are ~ound to th~ surface will remain bound to the surface and
not diffuse into solution.
Signal producing ~ystem - the signal producing
system has at least two members: (1) a cakalytic member; and
3S ~2) a solute, which undergoes a reaction cataly~d by the
catalytic member, which leads directly or indirectly to a
product on or in ~he surface which provides a detectible
signal. Desirably, a third compound will be present which
.
` ~3~`3~
provides for enhanced rate of change of the signal generatlng
compound at the surface as compared to the bulk solution.
This can be as a result of the component be:ing bound to the
surface or interactin~ with another member of the signal
producing system.
The catalytic member may be enzymatic or non-
enzymatic, preferably enzymatic. Whether one or more than
one enzyme is employed, there will be at least one enzyme
bound to a mip. ~An enzyme acting as a catalyst should be
distinguished from an enzyme acting as a receptor.)
The solute can be any compound which is capable of
und~rgoing a reaction catalyzed by a catalytic member of the
signal producing system, which reaction results either
directly or indirectly in modulating the formation of a
detectible signal generating compound associated with the
surface. The association of the signal generating compound
to the surface may be as a result of insolubilization of the
product produced when solute undergoes the catalyzed reac-
tion, complexativn of the product with a compound on the
surface or reaction or interaction of a compound on the
surface with the product of the catalyzed reaction.
The signal generating ~ompound will provide an
electromagnetic signal, e g. a spectrophotometric or visible,
electrochemical or electronic detectible signal. The signal
generating compound will be ~ssociated with the surface due
to its insolubility, or covalent or non-covalent binding to
the surface. The observed detectible signal rom the surface
will be related to the amount of catalyst bound to the sur-
face through the binding o the catalyst-bound-mips to the
mip-bound-surface.
Various technigues and combinations of reagents may
be employed to enhance the production of the detectible
signal at the surface, while minimizing intererence from
materials in the bulk solution.
Label - the label may be any molecule conjugated to
another molecule where each of the molecules has had or can
have had 2 prior discrete existence. For the most part,
labels will be compound~ conjugated to a mip. In referring
,,
. ............ .. .. ..
..
to a catalyst conjugated to an antiligand, the reagent will
be referred to as a cataly~t~bound-antiligand, while for a
ligand conjugated to a surface, the reagent will be referred
to as ligand-bound surface.
Method
_
The subject assay is carried out in an aqueous zone
or medium, where the final assay medium may be the result of
prior individual additions of reagents or combinations of
reagents and incubations, prior separations involving removal
of the surface from an aqueous medium and transfer to a
different aqueous medium having one or more reagents, or
combinations thereof. The subject method, however, does not
require a separation of catalyst-bound-mip which is unbound
from that which is bound to its homologoùs partner bound to
the surface (mip~-bound-surface). The medium consists of a
liquid phase and a non-fluid phase which is the "surface."
In carrying out the assay, the mip-bound surface
will be contacted ~y the sample, and by the members of the
signal producing system, and any ancillary materials in an
aqueous medium, either concurrently or stepwise, to provide a
detectible signal associated with the surface. The detecti-
ble signal will be related to the amount of the catalyst-
bound-mip bound to the surface, which in turn will be related
to the amoun~ of analyte in thè sample. Depénding upon the
nature of the signal produ~ing system and the desired method
for detec-ti.ng the ~ignal, the surface may be xead in the
assay medium or will be read separate from the assay medium.
In carrying out the assay, an aqueous medium will
normally be employed. Other polar solvPnts may also be
included, usually oxyyenated organic solvents of from 1-6,
more usually from 1-4 carbon atoms, including alcohols,
ethers and the like. Usually these cosolvents will be
present in less than about 40 weight percent, moxe usually in
less than about 20 weight percent.
The pH for the medium will usually be in the range
of about ~-11, more u~ually in the range of about 5-10, and
preferably in the range of about 6.5-9.5. The pH i~ chosen
so as to maintain a significant level of specific binding by
~3~3;~
11
the receptor while optimizing signal producing efficiency.
In some instances, a compromise will be made between these
two considerations. Various buffers may be used to achieve
the desired pH and maintain the pH during the determination.
Illustrative bufEers include borate, phosphate, carbonate/
Tris, barbital and the like. The particular buffer employed
is not critic~l to this invention but in individual assays,
one buffer may be preferred over another.
Moderate tempera-tures are normally employed for
carrying out the assay. Constant temperatures durin~ ~he
period of the measurement are generally required only if the
assay is performed without com~arison with a control sample.
The temperatures for the determination will generally range
from about 10-50~C, more usually from about 15-45C.
The concentration of analyte whlch may be assayed
will generally vary from about 10 4 to 10 15M, more usually
from about 10 6 to 10 13M. Considerations such as whether
the assay is qualitative, semi quantitative or guantitative,
the particular detection technique and the concentration of
t.he analyte of interest will normally determine the concen-
tration of the other reagents.
The concentrations of the various reagents will
vary widely depending upon which protocols are employed, the
nature of the analyte, the mip which is bound to the surface
and the mip which is bolmd to the catalyst, the required
sensitivity of the assay, and the like. In some instances,
large excesses o one or the o~ler of the mips may be em-
ployed, while in some protocols the sensitivity of the assay
will be responsive to variations in the mip ratios.
By way of illustration, if the analyte is a poly-
epitopic antigen, one could have excesses of antiligand as
antiligand-bound~surface and as catalyst-bound-antiligand,
without seriously affecting the sensitivity of the assay,
provided that the surface is first contacted by the sample,
followed by contact with the ~ignal producing system. Where
antiligand is the sample and the protocol involves the com-
bination of the analyte and cataly~t-bound-antiligand prior
to contacting ~he antigen-bound-surface, the sensitivity of
.
.
~3~
the assay will be related to the ratios of ~he analyte and
catalyst bound~antiligand concentration.
In addition to the considerations involving the
protocol, the concen-tration of the reagents will depend on
the binding constant of the antiligand, the binding constant
profile for a particular antisera, as well elS the required
sensitivity of the assay. Also, when all 0.1-- the signal
producing system is present in the liquid phase, the catalyst
substrates and ancillary reagents should be at a concentra~
tion which allows for substantial immunological pair binding
befcre a large amount of signal producing product is formed.
Where the sensitivity of the assay is concentration related,
fre~uently the particular concentrations wilI be determined
empirically. When the sample i6 combined with the homologous
catalyst bound-mip, generally the total binding site concen-
tration of the catalyst-bound-mip will be not less than abou-t
0.1 times the minimum concentration of interest based on
binding sites of analyte and usually not more than ahout
1,000 times the maximum concentration of interest based on
analyte ~inding sites, usually about 0.1 to 100 times, more
usually about 0.3-10 times the maximum concentration of
interest. When the analyte is preadsorbed to the mip-bound-
surface, the concentration of catalyst-bound-mip will depend
on the desired rate of ~inding to the surface, the production
of interfering signal generating compound in the liguid
phase, the cost of the reagent, etc.
The concentration of catalyst-bound mip will be
chosen so that the amount of catalyst~bound~mip in the void
~olume-llquid immediately adjacent to and occluded in the
surface will not significantly interfere with the measurement
of the change in concentration of the signal generating
compound at the sur~ace as a result of catalyst~bound-mip
bound to the surface. The chosen concentration will be
affected by the sensitivity of the measurement, the degree of
quantitation desired, the accuracy with which one must dis-
tinguish the lowest concentration of interest and the like.
In most situations, the ratio of concentration in
the void volume of catalyst bound-mip unbound to the surface
~3~3~
to catalyst-bound-mip bound to the surface should be not
greater than about 100 fold, usually not greater than about
10 fold at the ma~imum concentration of interest of the
analyte, preferably at the mid-range concentration range of
int~rest of the analyte.
The combination of the solid surface with the
sample may be prior to, concomitant with, Ol. subsequent to
combining the catalyst-bound-mip with the sample. By employ~
ing a single unit or entity as the sllrface, one can use the
surface to concentrate the analyte in a large sample. Also,
the surface allows for removal of the analyte from other
materials in the sample which could interfere with the deter~
mination of the result. Therefore, a preferred embodiment
will be to con~ine the surface with the sample, followed by
removal of the surface from the sample containing medium and
transfer to the assay medium.
Alternatively, one could leave the surface in
contact with the sample and add the remaining reagents. It
is also feasible, although in some instances no-t desirable,
to combine the sample with the catalyst-bound-mip, followed
by introduction of the surface into the assay medium. For
example, with a ligand analyte, en2yme-bound-antiligand and
ligand-bound-~urface, this last technigu could be effective-
ly used.
Fre~uently, the last of ~he components of the
signal producing system will be added at about the same time
as the catalyst-bound-mip, without any intermediate step,
such as separating or washing the sur~ace.
Where a receptor is the analyte, instead of having
a single immunological pair, one may employ two immunological
pairs, where the receptor acts as the ligand in one pair and
the receptor in the o~her. For example, with IgE, one could
bind the allergen or antigen to the surface and bind the
catalyst to anti-IgE. In this way, the IgE acts as a bridge
between two mips which in themselves cannot interact. In
referring to a mip, this situation ~hould be considered a
~pecial case which is intended to be included.
, . :;.,, ' :
~3~3!`3~
1~
In developing protocols for the method, certain
basic considerations will govern -the order of addition and
the combinations of reagents. The first consideration is
that preferably where the surface-bound-mip and the catalyst-
bound mip are different members e.g. one is ligand and one isantiligand, the two will be brought together prior to or
substantially concomitant with combination w.ith the surface.
The catalyst-bound-mip and solute will preferably be combined
as a single reagent, e~cept when the ~olute i~ the substrate
of the catalyst-bound-mip. Frequently, the surface and
sample will be combined prior or nearly concomitant with the
addition of the other xeagents.
Various protocols`will have various degrees of
complexity. In the simpler protocols, there will be two
catalysts involved in the signal producing system, one which
is bo~md to a mip, and the other bound to the surface. One
catalyst, pr0ferably the surface-bound-catalyst, reacts with
the solute to pxoduce a first product. This first product is
acted on by the second catalyst, which first product by
itself or in combination with other reagent~ produces a
second product which preferen-tially binds to the surface or
interacts with a compound bound to the surface, when produced
adjacent to the surface. This can be achieved conveniently
by producing a second product which i~ insoluble. By insolu-
ble is intended a solubility of less than about 10 3M. Theinsoluble product may effect changes in electrical properties
e.g. electrostatic or have spectrophotometric prcperties,
including absorption in -the ultraviolet or visible wavelength
range, chemiluminescence, reflectance and fluorescence,
preferably absorption.
In order to minimize the amount of repetition, a
table is provided which assembles various illustrative pro-
tocols. While the table is directed to polyepitopic anti-
gens, haptens can be employed in place o the antigens.
However, with haptens it will norrnally not be convenient to
bridge between receptors, ~nd in protocols that require
bridging, the addition of a poly~ligand analog) is required
to provide the bridging. When the analyte is a hapten, one
~3~
will normally add the hapten containing sample to the
xeceptor. When the catalyst bound-mip is ~he receptor, the
mip bound to the 6urface is normally hapten. When the mip
bound to the surface is a receptor, the mip bound to the
catalyst is normally hapten. Thus, one will normally satur-
ate a portion of the receptor binding sites with the hapten
analyte and cause the remaining s.ites to combine with the
hapten either conjugated to the surface or to the catalyst.
The antigen or polyepitopic analyte a~ a ligand
offers additional flexibility in that the xeceptor may be
bonded to both the catalyst and surface, without addeA
poly(ligand analog). Where the llgand is bonded to the
surface, the ligand analyte and thè ligand on the surface may
compete for a limited amount of labeled receptor or a
polyvalent receptor act as a bridge between ligand-bound-
surface and catalyst-bound-ligand. Where receptor is bound
to the surface, the ligand may then act as a bridge binding
simultaneously to the receptor-bound-surface and catalyst-
bound-receptor, ~o as to bind catalyst-bound-receptor to the
surface. In the latter situation, where the receptor-bound-
surface and ligand containing sample are combined prior to
addition of ~he catalyst-bound-receptor, one can have a large
excess of labeled receptor since the ~mount of labeled recep-
tor which ~inds to the surface will be directly related to
the amount of ligand bound to the surface. Where receptor-
bound-surface is employed with a receptor analyte, the two
receptors may complete for a limited amount of catalyst-
bound-antigen.
Where ligand is the analyte and ligand is bound to
the surface, one will normally first combine the sample
containing ligand with catalyst-bound receptor, so that the
li~and and catalyst-bound-receptor may bind and caus~ a
reduction in the number of available sites of ~he receptor
that can be scavenged by the ligand bound to ~he surface.
Where receptor is bound to the surface, and ligand is the
analyte, any order of mixing will be operable, although it
would usually be desirable to combine the sample with the
surface~ before co~tacting the surface wi~h the catalyst~
.
,
:
3~
16
bound-receptor. Normally, the formation of siynal generating
compound will be followed as a rate, observing the change in
signal on the surface with time. The rate of course will be
related to the amount of label which binds -I;o the ~urface.
This measurement may be made prior to establishing full
equilibrium between the analyte, catalyst-bound--mip and
mip-bound-surface, and thus the rate may vary with time.
TABLE I
Protocols
.
_ _ Materlals Added1 _
Surface Conjugated Anc.
2 mip ~e Sample Solute Reagent
fAg ~-Catl Ag ~ +
II 1 Ab-Cat1 Ag
2fAg +
III 1 fAb Ab-Catl Ag + +
IV 1fP~D Ag
Ab-Catl +
V 1Cat2fAg Ab-Catl Ag ~ +
20 VI 1 Ab-Catl Ag + +
2cat2f~g
VII 1 Cat2~Ab Ab-Catl Ag ~ +
VIII 1 Cat2fAb Ag
2 Ab-Catl ~ +
25 IX 1RfAb Ab-C~tl Ag + +
X 1RfAb Ag
2 Ab-Catl ~ -~
XI 1 Ab-Catl Ag
2RfAb + -~
30 XIII 1 fAg Ab-Catl ~b + +
XIV 1 RfAg Ab-Catl ~b ~ -~
XV 1 Cat27~g Ab~Catl Ab +
Surface mip - member of an immunological pair bound to a
surface in addition to other members of the si~nal
producing sys-tem. The f s~mbolizes the surface. ~g and
~3~3;2
Ab mean ligand and antiligand respectively, bound
covalently or non-covalently to the surface, where in
any given protocol the roles of ~b and Ag may be
reversed.
Cat2 - means a catalyst, usually an enzyme,
which cooperates with another catalyst usually an
enzyme as members of the signal producing system.
R - reagent, bound covalently or non~covalent
ly to ~he surface which reacts wilh the product of
a catalyst as part of the si~nal producing system.
Conjugated mip - ligand or antiligand to which a catalyst,
usually an en~yme, is covalently bonded.
Catl - a catalyst~ usually an enzyme, which is
part of the signaI producing system and reacts with
the solute or product formed from -the solute.
Solute - a medium soluble compound which reacts with Catl or
Cat2 as part of the signal producing system.
Anc. reagents - any additional reagents necessary to the
signal producing system, including enzymes, enzyme
substrates and cofactors, activators, scavengers and the
like.
2Each line indicates that the materials on that line are
co~bined prior to the addition of any of the materials on the
next line. The materials on each line may be added concur-
rently or consecutively, although in many instances one or
the othe~ order of addition will be pre~erred. When the
surface is combined with the sample prior to addition of the
conjugated mip, the surface may or may not be separated from
~he sample prior to contacting the surface with the conju-
gated mip and other reagents. Incubation steps may be in-
volved between steps and between the addition of materials as
part of one step.
Various protocols can be invol~ed by using one or
more catalysts in combination with a solute and one or more
intermediate members of ~le signal producing system. In
developing the protocols, one is concerned with maximizing
the production of the signal, so that the signal generating
.
' ;
~3~3`~
18
molecule is preferentially produced at and on the surface.
Furthermore, it i6 desirable that the reagents be combined in
as few separate formulations as pos6ible, so as to minimize
the number of measurements and additions whlch are reguired.
Where one has a catalyst bound to a mip, which
reacts with the solute to produce a signal generator which
precipitates within the surface pores or channels, the sur-
face need not be separated from the assay medi~ for reading.
I f removed from the assay medium as a matter of convenience
in measuring the signal generator on the surface, it need not
be washed to remove any non-specifically bound signal genera-
tor or catalyst-bound-mip.
One can further enhance the localized production of
the signal generator at the surface by having two or more
catalysts, particularly.enzymes. By employing as a solute a
substrate of one of the enzymes, preferably an enzyme bound
to the surface, where the product resulting from the solute
is the substrate for another enzyme, normally bound to a mip,
one can significantly minimize the rate of production of
signal generating compound in ~he bulk solution produced by
the enz~me bound to the mip. In effect, by having the sub-
strate for the catalyst bound-mip produced at the surace,
one can minimize the rate of production of signal generating
compound produced in the bulk solution, since the concentra-
tion of such substrate in the bulk solution will generally be~uite small.
In addition to haviny substrate produced at the
surface, other techniques may be employed to minimize produ~-
tion of the signal generating compound in the bulk solution.
For example, in the example given above, one could employ a
scavenser in the bulk solution which would act upon the
product of the solute~ to prevent its further reaction.
Alternatively, or in addition, one can employ an enzyme
inhibitor, which is added after binding of the enzyme-bound-
mip to the surface which is effective with the enz~me in thebulk solution, but not effective with enz~me bound to the
surface. A further alternative, is to have a reagent which
is bound to the surface, which reacts with the enzyme product
to produce the signal generating compound.
~ ~3~ Z
19
Another protocol involves the use of an enzyme-
bound-mip which prevents the formation of the signal produc~
ing substance on the surface. ~or example, an enzyme may be
bound to the surface which catalyzes the conversion of the
solute to an intermediate product. A seconcl enzyme bound to
the surface is employed to convert this intermediate product
to the signal generating compound. The enz~e-bound~mip
employs ano~hex enzyme that can react with the intermediate
product w.ithout forming the 6ignal gPnerating compound. When
the enzyme-bound mip becomes bound to the surace it inhibits
the ormation of the signal generating compound on the sur-
face. This pxotocol provides the advantage that a minimum
signal is produced when the catalyst-bound-mip is maximally
bound to the surface. Thus for certain protocols in which
the analyte and the catalyst-bound-mip compete for mi~-bound-
surface binding sites, the absence of analyte gives a minimum
signal and the presence of analyte gives an incroased signal.
In accordance with the above protocols, a signal
generating compound is produced or destroyed at the surface
20 iIl xelation to the amount of analyte in a sample. The signal
generating compound which is bound to the surface will be
substantially unrelated to the amount of signal generating
compound, if any, produced in the bulk solution. That is, to
the extent that a signal generating compound i~ produced in
the bulk solution, the amount which may diffuse from the bulk
solution to the surface and bé bound to the surface will be
negligibly small compared to the amount of signal gQnerating
compound produced at the solid surface at the minimum signal
level for ~he concentration xange of interest of the analyte.
The choice in bindins the ligand or receptor to the
surface will depend on a number of factors. When a polyepi-
topic ligand is the analyte, the use of catalyst~bound- ^-
receptor enhances the assay response by permittin~ many
catalysts to become bound to each molecule of the analyte
that binds to the surface. The purity of the li~and or
receptor will also be of significance. Since anti~era are
frequently heterogeneou~ and may have only a small proportion
of the desired receptox, the use of catalyst-bound-receptor
'
may produce excessive amounts of signal generating compound
in the bulk solution. One should therefore compare the
purity of the ligand to the receptor in determining to which
mip the catalyst should be conjugated. Furthermore, since in
5 many situations the concentration of the analyte of interest
will be extremely low, the binding of -the members of the mip
may be relatively slow. Therefore, if one can use a large
excess of the mip on the surface homologous to the analyte,
the rate of binding of the analyte and the :resultant develop-
ment of the signal generating compound at the ~urface can begreatly enhanced.
Another consideration is the convenience and effi-
ciency of combining the maximum number of rea~ents in the
fewest number of formulations. By emp1oying a system with
two or more catalysts, one can combine an enzyme catalyst
with the substrate of another en~,yme, referred to as the
solute. In addition, one can also combine any ancillary
reagents necessary for the two catalysts in a single reagent,
since the catalytic r~action of the enzyme cannot occur until
the other enzyme produces its substrate.
As is evident, the orders of addition and combina-
tion of the various reagents, including the introduction of
the surface into the assay medium can be varied widely.
Where there is a compekition for a limited number of binding
sites, either of the ligand or the receptor, normally the
sample will be initially bound to its homologous mip ~ coun-
terpart) prior to the addition of a competitive analogous
mip. Or, all of the reag~nts may be combined simultaneously.
The other reagents necessary for producing the signal gener-
ating compound may then be added concurrently with the analo-
gous mip or subsequent to combining the analogous mip. In
addition, it will be desirable, particularly where the signal
producing system employs a single catalyst, that the rate of
formation of the signal generating compound in the assay
medium be affected by a component which differentiates
between the surface and the bulk solution. Factors such as
the control of local change, pH, solute concentrations, etc.
on the surface can be employed to produce differential enæyme
actlvity.
3Q~
21
Frequently, when one is combining the sample with
its homologous mip bound to the surface, an incubation step
will be involved, to allow for a s~stantial c~mount of the
analyte to bind. A second incubation step may be involved
where the catalyst-bound-analogous mip combines with the
remaining bindlng sikes of the homologous mip-bound-surface
or where the ligand acts as a bridge for two receptors, one
conjugated to ~he surface and the other conjugated to the
catalyst label. Whether a second incubation step is involved
will depend to a substantial degree on the rate of binding,
the sensitivity re~uired for the assay, and the rate of
production of signal generating compound at the solid sur-
face. Conveniently, one combines the catalyst-bound-mip and
remaining members of the signal producing system substantial-
ly concurrently and allows the signal generating compound tobe produced while the catalyst-bound-mip is bindin~ to the
surface.
The followiny are illustrative of a few exemplary
protocols. In the first exemplary protocol, a single enzyme
catalyst is employed, which is bound to a receptor e.g.
antibody. A porous surface is employed to which is also
bound receptor. The sample containing polyepitopic li~and
analyte i~ combined with the antibody-bound-surface and the
mixture incubated for a sufficient time, so ~hat a detectable
amount of analyte would have had an opportunity to bind. To
the mixture is then added the enzyme-bound antiligand and the
mixture incubated again for a sufficient time for a detect-
able amount of the enzyme conjugate to bind to ligand bound
to the surface. Buffer may be included with the enzyme-
bound~antiligand to enhance the binding of the enzyme conju-
gate to the ligand.
After sufficlent incubation, the solùte and any
other reagents fox measuring enzyme activity may be intro-
duced as a single reagent, including an agent which enhances
3~ the enzyme activity at the surface as compared to the bulk
solution, for example, a macro-molecular enzyme inhibitor
e.g. polyantienzyme. The i~hibitor would be sterically
precluded from binding to enz~me bound to the surface.
~L3~
22
Alternatively, one or more or all of the necessary substrates
or cofactors may be combined with the enzyme-bound-antiligand
and introduced with khe enzyme-bound-antiligand into the
assay medium. So long as an essential component for the
S enzyme reaction is withheld, the other reagents necessary for
the enzyme reaction may be included with the enzyme as a
single reagent. After adding the necessary reagents for the
enzyme reaction, one can wait a sufficient time period for
the signal generating compound to be produced within the
porous surface and compare the signal thus produced to a
reference signal, e.g. signal produced with a known amount of
analyte. Alternatively, one could take two readings and
determine the change in intensity of the signal with time.
Another pQssibility is after a predetermined time from the
complete addition of all o the substrates and cofactoxs
necessary for the enzyme, the surface is removed and read
outside of the assay medium.
As distinct from using the ligand as a bridge, a
hapten analyte is illustrative of a competition mode. In
this exemplary protocol, the sample containing the hapten
analyte would be combined with enzyme-bound-receptor and the
hapten-bound-surface to which is bonded a precursor to the
~ignal generating compound and, as appropriate, the mixture
incubated for a sufficient time for the haptén to bind to the
receptor and the enzyme-bound-receptor to the ~urf~ce. The
solute and ancillary reagents are then added to the assay
medium where the enz~me produces a product which reacts with
the precursor to produce the signal generating compound. One
could then take one or more readings at predetermined time
intervals to determine the rate at which the ~ignal generat~
ing compound is produced on the solid surface, which would be
related to the number of available binding sites of ~he
receptor after binding of the hapten analyte in the sample.
Another alternative with a single enzyme is to
employ an oligomeric substrate with an exohydrolase. For
example, one could have a disaccharide bonded to a dye which
provides ~ colorless reagent, which on removal of the sugar
provide~ an insoluble colored dye. Slnce the di~accharide
~31~
requires two en~matically catalyzed hydrolyses, in effect
one has a third component since the one enzyme acts on two
different substrates. There is, therefore, an analogous
situation to the two enzyme system, where the action of one
enzyme in a first stage produces as a product a substrate for
a second en~yme, which acts in a second stage. With such a
substrate, the inclusion of an agent that enhances the enz~me
a~ti~ity at the sur~ace as compared to the bulk solution is
of less importance.
In a third exemplary protocol, employing two
enzymatic catalystsl both an enzyme and antibody would be
bound to the surface ( en7yme and antibody bound-surface).
The surface would be combined with a polyepit~pic antigen
analyte and the mixture inoubated for a sufficient time for
the antigen to bind to the receptor on the surface. Normal-
ly, the binding of the antigen will be performed in the
undiluted sample. To the mixture may then be added as a
single reagent the enzyme catalyst bound receptor, the
solute, which is the substrate for the enzyme bound to the
surface, and the remaining reagents/ including any additional
precursors to the signal generating compound where the pro-
duct resulting from the solute i~ not the only precursor to
the signal generating compound. Alternatively, the surface
can be transferred to this single reagent. As previously
indicated/ the signal may be read on the surface-in ~he assay
medium/ or the surface may be removed from the assay medium
and read elsewhere. The signal which is detectable from the
surface will be proportional to the amount of catalyst-bound-
mip bound to the surface, which in turn is proportional to
the amount of analyte in the sample.
In~tead of having a second enzyme on the surface,
one could bind two different enzymes on different mips,
either both on ligands or both on receptors, or bcth enzymes
on the same mip. The significant factor is that the immuno-
logical pair binding results in the enhanced localized concentration of two members or molecules of the signal produc-
ing system at the ~urface, which members interact to enhance
the change in concentration of the signal generating com~
pound, wi~hout reacting with each other.
3~
24
The employment of a two stage process for modula
tion of the signal generating compound may or may not involve
a third reagent in addition to the solute and catalyst-bound-
mip as a component of the signal producing e;ystem. The
significant factor is that the immunological binding at the
surface provides an opportunity for concentrating components
of the signal producing system at the surface as compared to
the bulk solution.
Where the cooperation or interaction of the compo-
nents of the signal producing system in the overall rate ofproduction or destruction of the signal generating compound
is related to the average spatial proximity of the components
of the signal producing system, the binding of the catàlyst-
boun~-mip through immunological pair ~inding to the surface
permits enhancement of the locallzed concentration of compo-
nents of the ~ig~al producing sy~tem as compared to the bulk
solution, so as to minimize the effect of any generation of
signal generating compound in the bulk solution on the amount
of signal generating compound at the ~urface.
Alternatively or in addition, a scavenger can be
added which preferentially reacts or interacts with a compo-
nent of the signal producing system other than the solute in
the bulk solution. The scavenger acts to interfere with the
operation of the signal producing system in the bulk solution
by either preventing a catalyzed or non-catalyzed reaction
from proceeding or preventing a signal generating compound
from generating a signal.
Normally, the sisnal will be by observation of
electromagnetic radiation, particularly ultraviolet or visi
ble light, either absorption or emission, particularly ab
sorption, or electrical properties of the surface. Desir-
abl~, light will be in the range from about 250 to 800nm,
usually fxom about 350 to 700nm. Visual inspection~ reflec-
tometers, fluorometers, spectrophotometers or the like may be
employed, depending upon the signal ~enerating compound and
the nature of the surface, that is, whether opaqu2 or krans-
parent. Usually, it will be the intensity (transmission or
emission~ of the signal yenerator on the s~lrface which will
be correlated with the amount of analyte.
.
3~
The temperature at which the signal is observed
will generally range from about -lso to 50C, more usually
from about 15 to 40C.
5tandard s~mples can be prepared which ~ave known
amounts of analyte. The observed signal for each of the
standard samples may then be plotted or compared visually, so
as to relate concentration to signal. Alternatively, a
number of surfaces may be prepared relating to various con-
centrations, and visual or spectroscopic comparison made
between the surface of the sample and the standards. Depend-
ing upon the accuracy re~uired, the ~tandards may be made as
a prior color chàrt or may be made ~y the analyst determining
the sample. Once a standard curve has been established, an
observed signal may be directly related to the concentration
of the analyte.
In a preferred method for calibration, a surface is
employed that is identical to the surface employed in the
assay but without a mip bound to it. For the assay of a
polyepitopic anti~en using receptor-bound-surface and
catalyst~bound-receptor, the failure of catalyst-bound-
receptor to bind to the surface indicates that no antigen is
present in the sample. Since the calibration surace cannot
bind catalyst-bound-receptor even in the presence of anti~en,
the surface provldes a suitable comparison for ~egative
samples when subjected to the iclentical protocol as the
mip-bound surface employed with the sample. By comparing the
signal from the calibration surface with the signal from ~he
mip-bound-surface, any difference is indicative of the
presence of antigen.
Another alternative .is to employ a calibration
~ystem involving mips different from the analy~e and its
homologous mip. Conveniently, one would modify the catalyst
or catalyst bound-mip with a hapten recognized by a receptor
bound to the calibration surface or employ a receptor for a
natural site on the catalyst or catalyst-bound-mip unrelated
to the specific mip binding.
By adjustment of the concentration of the receptor
on the calib~ation surface a simulated assay response can be
!
'
', ' ~
:' :
. ~ .
~3~
26
produced that is identical to ~he signal produced by a pre~
determined (usually zero3 concentration of analy~e.
As stated above, the calibration surface and the
assay surface (mip-bound-surface) are subjected to identical
assay conditions and the signals compared. Depending upon
whether an increase or decrease in signal results Erom an
elevation in analyte concentration, a difference in signal
between the calibration surface and the ass~y sur~ace in the
appopriate direction would indicate the presence of analyte.
The time for measuring the signal will be basecl on
such factors as the sensitivity re~uired, concentration of
analyte, rate o~ bindi~g, nature of the signal producing
system, etc. Since at zero time there is no chan~e in the
initial signal, a single measurement need only be made at the
end of the final incubation. For better quantitation, mea-
surements could be made at intervals during the incubation,
with incubation time varying from 5secs to 36hrs.
The ligand analyte may be mono- or polyepitopic.
Except ~hat a hapten cannot be employed as a brldge between
the receptor bound to the ~urfac~ and catalyst-bound-
receptor, hapten and antigen analytes can be treated analo-
gously. If a bridge is desired, a poly(ligand analog) may be
employed having a plurality of haptens joined together and
employiIlg a limited amount of catalyst-bound-receptor. In
this protocol, the receptor-bound-surface would be co~bined
with the sample and poly(ligand analog), followed by addition
of catalyst-bound-receptor. Of course, one could replace the
poly(ligand analog~ and catalyst-bound-receptor, by hapten
conjugated to the catalyst (hapten-bound-catalyst).
Where the receptor is the analyte, one can allow
for competition between the receptor analyte ahd receptor-
bound surface for a limited amount of catalyst-bound-ligand.
For a receptor analyte, alternatively, one could employ the
antigen as a bridge as described pr viously, where the recep-
tor analyte competes with catalyst~bound-receptor for the
antigen bound to the receptor as recep-tor-bound-surface.
In ~he event that the analyte, the mip bound
surface, and the catalyst bound-mip are all the same member,
~3~
27
then the homologous member must be added and in polyepitopic
form either, for example, for receptor, as an anti.body or a
polyvalent receptor, where the receptor is other ~than an
antibody, or or ligand, as polyhapten (poly(ligand analog))
or polyepitopic an-tigen.
The subject method lends itself to the determina-
tion of a plurality, two or more, analytes simultaneously.
By having a surface e.g. a strip, with a plurality of mips
for different analytes, e.g. antigens, so that each mip is
localized at a particular position on the solid surface, in
combination with a plurality o~ catalyst-bound-mips, specific
for each analyte, generation of sIgnal at each site would be
indicative of different analytes.
Materials : .
The components employed in the subject assay will
be the analyte; the surface; the signal producing system; and
as appropriate poly(ligand analog) or polyvalent receptor.
The signal producing system will have at least two members,
the catalyst-bound-mip and the solute, frequently having
additional members.
Analyte
The ligand analytes of this invention are charac-
terized by being monoepitopic or polyepitopic. The poly-
epitopic ligand analytes will normally be poly~amino acids)
i.e. polypeptides and proteins, ~olysaccharides, nucleic
acids, and combinations thereof. Such combinations of assem
blages include bacteria, viruses, chromosomes, genes,
mitochondria, nuclei, cell membranes, and ~he like.
For the most part, the polyepitopic ligand analytes
employed in the subject invention will have a molecular
weight of at least about 5,000, more usually a:t least about
lO,000. In the poly(amino acid) category, the poly(amino
acids~ of interest will generally be rom about 5,000 to
5,000,000 molecular weight, more usually from about 20,000 to
l,000,000 molecular weight; among the hormones of interest,
the molecular weights will usually range ~rom about 5,000 to
60,000 molecular weight.
.'
28
The wide variety of proteins may be considered as
to -the family of proteins having similar structural features,
proteins having paxticular biological function~, proteins
related to specific microorganism.s, particularly disease
causing microorganisms, etc. For cells and viruses,
histocompatability antigens or surface antigens will fre~
~uently be of interest.
The following are classes of proteins related by
s-tructure:
protamines
histones
albumins
globulins
scleroproteins
phosphoproteins
mucoproteins
chromoproteins
lipoproteins
nucleoproteins
glycoproteins
proteoglycans
unclassified proteins, e.g. somatotropin,
prolactin, insulin, pepsin
A number of proteins found in the human plasma are
important clinically and include:
Prealbumin
Albumin
al-Lipoprotein
al-Acid ~lycoprotein
al-Antitrypsin
al-Glycoprotein
Transcortin
4.6S-Postalbumin
Tryptophan-poor
~l-glycoprotein
29
alx-Glycoprotein
Thyroxin-binding glo~ulin
Inter ~-trypsin-inhibitor
Gc~globulin
~Gc l-l)
(Gc 2~1)
(Gc 2-2)
~I~ptoglobin
~Hp l-l)
~Hp 2-1)
(~p 2-2)
Ceruloplasmin `
Cholinesterase~
a2-Lipoprotein(s)
Myoglobin
C-Reactive Protein
a2-Macroglobulin
a~-HS-glycoprotein
Zn-~-glycoprotein
a2-Neuramino~glycoprotein
Erythropoietin
~-lipoprotein
Transferrin
Hemopexin
Fibrinogen
Plasminogen
~-glycoprotein I
~2 glycoprotein II
Immunoglobulin G
(IgG) or yG-globulin
~ol. formula:
y2K~ or y2A2
Immunoglobulin A (I~A)
or yA-globulin
Mol. fo~mula:
(~2K2~ or (a2A2)
Immunoglobulin M
(IgM) or yM~globulin
:
:, ~ , , . :
.
Mol. formula:
(~2K2)5 ~r ~A~)5
Immunoylobulin D(I~D)
or yD-Globulin (yD3
~ol, formula:
(~2K2) or ~A2
Immunoglobulin E (IgE~
or yE-Globulin (yE)
Mol. formula:
(2K2) ~ (2 2~
Free K and A light chains
Complement factors:
C'l
~ ' l q
C'lr :
C'ls
Cl2
C'3
~lA
~2D
C'4
C'5
C'6
C'7
C'8
C'9
Important blood clotting factors include:
BLOOD CLOTTING FACTORS
30 International designation Name
.
I Fibrinogen
II Pxothrombin
IIa Thrombin
III Tissue thromboplastin
V and VI Proaccelerin, accelera-tor
globulin
~3~
31
VII Proconvertin
VIII Antihemophilic globulin
~AHG3
IX Christmas factor,
plasma thromboplastin
component ~PTC)
X Stuart-Pxower factor,
autopro~hro~bin III
XI Plasma thromboplastin
antecede:nt (PTA)
XII Hagemann factor
XIII Fibrin-~tabilizing factor
., , '~
Important protein hormones include:
~etide and Protein Hormones
.
Parathyroid hormone
(parathromone)
Thyrocalcitonin
Insulin
Glucagon
Relaxin
Eryt~ropoietin
Melanotropin . ~ -
(melanocyte-stimulating
~5 hormone; intermedin)
Somatotropin
(growth hormone)
Corticotropin
(~drenocorticotroplc hormone)
Thyrotropin
Follicle-stimulating hormone
Luteinizing hormone
(interstitial cell-stimulating
hormone)
3~ Luteomammotropic hormone
(luteotropin, prolaGtin)
Gonadotropin
(chor1onic gonadotropin3
.. ..
.
; .
3~
32
Tissue ~ormones
_ _ _
Secretin
Gastrin
Angiotensin I and II
Bradykinin
~uman placental lactogen
Peptide Hormones from the Neurohypophysis
Oxytocin
Vasopressin
Releasing factors (RF3
CRF, LRF, TRF, Somatotropin-RF,
GRF, FSH RF, PIF, MIF .
Other polymeric materials of interest are
mucopolysaccharides and polysaccharides.
Illustrative antigenic polysaccharides derived
from microorganisms are as follows:
Species of Microorganisms Hemosensitin Found in
Streptococcus pyogenes Polysaccharide
Diplococcus pneumoniae Polysaccharide
20 Neisseria meningitidis Polysaccharide
Neisseria gonorrheae Polysaccharide
Corynebacterium diphtheriae Polysaccharide
Actinobacillus mallei; Crude extract
Actinobacillus whitemori
25 Francisella tularensis . Lipopolysac-
charide
Polysaccharide
Pasteurella pestis
Pasteurella pestis Polysaccharide
30 Pasteurella multocida Capsular antiyen
Brucella abortus Crude extract
Haemophilus influenzae Polysaccharide
Haemophilus pertu~sis Crude
Treponema reite A Polysaccharide
35 Veillonella Lipopolysac-
charide
Erysipelothrix Polysaccharide
1isteria monocytogenes Polysaccharide
' .`~
` ~3~3~
Chromobacterium ~ipopolysac-
charide
Mycobacterium tuberculosis Saline extract of
90% phenol
extracted
mycobacteria
and polysac-
charide
fraction of
cells and
turberculin
Klebsiella aerogenes Polysaccharide
Klebsiella cloacae Polysaccharide
Salmonella typhosa - Lipopolysac-
charide,
Polysaccharide
Salmonella typhi-murium; Polysaccharide
Salmonella derby
Salmonella pullorum ::
20 Shigella dysenteriae Polysaccharide
Shigella flexneri
Shigella sonnei . Crude, Poly-
saccharide
Rickettsiae . - -Crude extract
25 Candida albicans Polysaccharide
Entamoeba histolytica Crude extract
The microorganisms which are assayed may be intact,
lysed, ground or otherwise fragmented, and the resulting
composition or portion, e.g. by extraction, assayed. Micro-
organisms of interest include:
Corynebacteria
Cor~nebacterium diptheriae
Pneumococci
.
Diplococcus pneumoniae
Streptococci
Streptococcus pyogenes
Streptococcus salivarus
, , . ,, , ~
- . - ,. : : ,: : "
- .
.. . ~ ,.
.. . . ~ .
~3~
Staphylococci
Staphylococcus aureus
Staphylococcus albus
~eisseriae
Neisseria meIlingitidis
Neisseria gonorrheae
Enterobacteriaciae
Escherichia coli
Aerobacter aerogenes ~ The coliform
Klebsiella pneumoniae ¦ bacteria
Salmonella typhosa .
. Salmo~ella choleraesuis ~ The Salmonellae
Salmonella.typhimurlum J
Shigella dysenteriae
Shigella schmitzii
Shigella arabinotarda > The Shigellae
Shigella flexneri
Shigella boydii
Shigella Sonnei
Other enteric bacilli
\
Proteus vulgaris ....... 1
Proteus mirabilis ~ Proteus species
Proteus morgani
Pseudomonas aeruginosa
Alcaligenes ~aecal:is
Vibrio cholerae
~emophilus-Bordetella_~rou~
Hemophilus influenzae, H. ducreyi
H. hemophilus
H. aegypticus
~. parainfluenzae
Bordetella pertussis
~3~
Pasteurellae
Pasteurella pestis
Pasteurella tulareusis
Brucella
Brucella melitensis
Brucella abortus
Brucella suis
Aerobic Spore-formin~ Bacilli
Bacillus anthracis
Bacillus subtilis
Bacillus megaterium
Bacillus cereus
Anaerobic Spore~-formlng_Bacilli -
Clostridium botulinum - .
Clostridium tetàni
Clostridium perfringens
Clostridium novyi
Clostridium septic~
Clostridium histolyticum
Clostridium tertium
Clostridium bifermentans
Clostridium sporogenes
Mycobacteria
Mycobacterium tuberculosis hominis
~ 25 Mycobacterium bovis
Mycohacterium avium
Mycobacterium leprae
Mycobacterium paratuberculosis
Actinomycetes (fungus-like bacteria)
A~tinomyces israelii
Actinomyces bovis
Actinomyces naeslundii
Nocardia asteroides
Nocardi~ brasiliensis
The Spirochetes
Treponema pallîdumSpirillum minus
Treponema pertenueStreptobacillus
moniliformis
. . ~ . ~.
36
Treponema carateum
Borrelia recurrentis
Leptospira icte.rohemorrhagiae
Leptospira canicola
coplasmas
Mycoplasma pneumoniae
Other patho~ens
Listeria monocytogenes
Erysipelothrix rhusiopathiae
Strep~obacillus moniliformis
Donvania granulomatis
Bartonella bacilliformis
Rickettsiae (bacteria like parasites)
,
Rickettsia prowazekii
Rickettsia mooseri
Rickettsia rickettsii
Rickettsia conori
Rickettsi~ australis
Rickettsia sibiricus
Rickettsia akari
Rickettsia tsutsugamushi
Rickettsia burnetii
Rickettsia quintana
Chlamydia (unclassifiable parasites ~acterial/viral)
Chlamydia age.nts Inamin~ uncertain)
Fun~i
Cryptococcus neoformans
Blastomyces dermatidis
Histoplasma capsulatum
Cocciaioides immitis
Paracoccidioides brasi~iensis
Candida albicans
Aspergillus fumigatus
Mucor corymbier (Absidia corymbifera)
Rhizopus oryzae
Rhizopus arrhizus ~ Phycomycetes
Rhlzopus nigricans
`
'
.
3~
Sporotrich~ schenkii
Fonsecaea pedrosoi
Fonsecaea compacta
Fonsecaea dermatidi.s
S Cladosporium carxionii
Phialophora verrucosa
Aspergillus nidulans
Madurella mycetomi
Madurella grisea
Allescheria boydii
Phialosphora jeanselmei
Microsporum gypseum
Trichophyton mentagrophytes
Keratinomyces ajelloi:
Microsporum canis
Trichophyton rubrum
Microsporum andouini
Yiru~es
Adenoviruses
Herpes Viruses
Herpes simplex
Varicella ~Chicken pox)
Herpes Zoster (Shingles)
Virus B
Cytomegalovirus
Pox Viruses
.
Variola (smallpox)
Vaccinia
Poxvirus bovis
Paravaccinia
Molluscum contagiosum
Picornaviruses
Poliovirus
Coxsackievirus
3S Echoviruses
Rhinoviruses
;
~3~3~
38
Influenza (A, B, and C)
Parainfluenza (1-4
Mumps Virus
Newcastle Disease Virus
Measles Virus
Rinderpesk Virus
Canine Distemper Virus
Respiratory Syncytial Virus
Rubella Virus
Arboviruses
Eastern Equine Eucephalitis Virus
Western Equine Eucephali~is Virus
Sindbis Virus
Chikugunya Virus
Semliki Forest Virus
Mayora Virus
St. Louis Encephalitis Virus
California Encephalitis Virus
Colorado Tick Fever Virus
~ellow Fever Virus
Dengue Virus
Reoviruses
Reovirus T~pes 1-3
2S Hepatitis
~epatitis A Virus
Hepatitis B Virus
Tumor Viruses
Rauscher Leukemia Virus
Gross Virus
Maloney Leukemia Virus
Epstein Barr Virus
Other Parasites Related to the Followin~ Diseases
Doy Heart Worm (microfilaria)
Malaria
Sc~istosomiasiæ
Coccidosis
Trichinosis
3~
39
The monoepitopic ligand analytes will generally be
from ~bout 100 to 2,000 molecular weight, more usually from
125 to 1,000 molecular weight. The analytes of interest
include drugs, metabolites, pesticides, pollutants, and the
like. Included among drugs of interest are the alkaloids.
Among the alkaloids are morphine alkaloids, which includes
morphine, codeine, heroin, dextromethorphan, their deriva-
tives and metabolites; cocaine alkaloids, which includes
cocaine and benzoyl ecgonine, their derivatives and metabo-
lites; ergot alkaloids, which includes the diethylamide oflysergic acid, steroid alkaloids; iminazoyl alkaloids;
~uinazoline alkaloids, isoquinoline alkaloids, ~uinoline
alkaloids; which includes guinine ~nd ~uinidine; diterpene
alkaloids; their derivatives and me-tabolites.
The next group of drugs includes steroids, which
includes the estrogens, gestogens, androgens, andrenocortical
steroi~s, bile acids, cardiotonic glycosides and aglycones,
which includes digoxin and digoxigenin, saponins and
sapogenins, their derivatives and metabolites. Also included
are the steriod mimetic substances, such as
diethylstilbestrol.
The next group of drugs is lactams having from 5 to
6 annular members, which include the barbitura~es, e.g.
phenobarbital and secobarbital, diphenylhydantonin,
primidone, ethosuximide, and their metabolites.
The next group of drugs is aminoalkylbenzenes, with
alkyl of from 2 to 3 carbon atoms, which includes the
amphetamines, catecholamines, which includes ephedrine,
L-dopa, epinephrine, narceine, papaverine, their metabolites.
The next group of drugs is aminoalkylbenzenes, wi~h
alkyl of from 2 to 3 carbon atoms, which includes ephedrine,
L-dopa, epinephrine, narceine, papaverine, their metabolites
and derivatives.
The next group of drugs is benzheterocyclics which
3X include oxa2epam, chlorpromazine, tegretol, imipramine, their
derivatives and metabolites, the heterocyclic rings being
azepine~, diazepines and phenothia%ines.
3~
The next group of drugs is purines, which includes
theophylline, caffeine, their metabolites and derivatives.
The ne~t group of drugs includes those deriYed from
marijuana, which includes cannabinol and
tetrahydrocannabinol.
The next group of drugs includes the vitamins such
as A, B, e.g. B12, C, D, E and K, folic acid, thiamine.
The next group of drugs is prostaglandins, which
differ by khe degree and sites of hydroxylation and
unsaturation.
The next group of dirugs is antibiotics, which
include penicillin, chloromycetin, actinomycetin,
tetracycline, terr~nycin, their metabolites and derivatives.
The next group of drugs is the nucleosides a~id
nucleotides, which include ATP, NAD, FMN, adenosine,
guanosine, thymidine, and cytidine withi their appropriate
sugar and phosphate substituents.
The next group of drugs is miscellaneous individual
drugs which include methadone, meprobamate, serotonin,
meperidine, amitriptyline, nortriptyline, lidocaine,
procaineamide, acetylprocaineamide, propranolol,
griseofulvin, valproic acid, butyrophenones, antihistamines,
anticholinergic drugs, such as atropine, thieir metabolites
and derivatives.
The ne~t group of compounds is amino acids and
small peptides which include polyiodothyronines e.g~
thyroxine, and triiodothyronine, oxytocin, ACTH, angiotensin,
met-and leu-enkephalin their met~bolites and derivativesO
Metabolites related to diseased states includie
spermine, galactose, phenylpyruvic acid, and porphyrin
Type 1.
The next group of drugs is aminoglycosides, such as
gentamicin, kanamicin, tobramycin, and amikacin.
Many drugs of interest will involve aralkylamine
structures, which may or may not be a part of a heterocyclic
structure, e.g. alkaloids, phenobarbitol, dilantin,
epinephrine, L-dopa, etc. While there is some similarity in
structure, the compounds vary widely as to activity.
~3~
41
Drugs may also be considered a~ to the primary
purpo~e for which they are used. In many situations, it is
desirable to monitor a drug for police functions, ~herapeutic
dosaye monitoring for drugs used for treatment of asthmatics,
epileptics, cardiovascular diseases, hypertension, bacterial
or viral infection, gastraintestinal infections, etc. In
each case, physiological fluids such a~ blood, serum, saliva,
etc. are monitored to ensure that the administered drug is
within the therapeutic dosage for the indiv:idual.
Among pesticides of interest are polyhalogenated
biphenyls, phosphate esters, thiophosphates, carbamates,
polyhalogenated sulfenamide~, thei-r metabol:ites and
derivatives.
For receptor analytes,.the molecular weights will
generally range from 10,000 to 2x106, more usually from
10,000 to 106. For immunoglobulins, IgA, IgG, IgE and IgM,
the molecular weights will generally vary from about 160,000
to about 106. Enzymes will normally range from about 10,000
to 6000,000 in molecular weight. Natural receptors vary
widely, generally being at least about 25,000 molecular
weight and may be 106 or higher molecular weight, including
such materials as avidin, thyroxine binding globulin,
thyroxine binding prealbumin, transcortin, etc.
Ligand Analog
The ligand analog will differ from the ligand
either by replacement of a hydrogen or a functionality with a
bond or a linking group which has a functionality for forming
a covalent bond to another molecule having an active func-
tionality, such as an hydroxyl, amino, aryl, thio, olefin,
etc., where the resulting compound differs from the ligand by
more than substitution of a hydrogen by the molecule to which
it is conjugated. The linking group will normally have from
1-20 atoms other than hydrogen, which are carbon, o~ygen,
sulfur, nitrogen, and halogen of atomic number 17-35. The
functionalities which are involved include carbonyl, both oxo
and non-o~o, active halogen, diazo, mercapto, ethylene,
particularly activated e~hylene, amino, and the like. The
number of heteroatoms will generally range from about 0-6,
;
~ ~3~33;~
42
more usually from about 1-6, and preferably from about 1-4.
A description of linking ~roups may be found in U.S. Pate~t
No. 3,817,837.
For the most part, the linking groups will be
aliphatic, although with diazo groups, aromatic groups are
involved. Generally, the linking group is a divalent chain
having about 1-10, more usually from about 1-6, atoms in the
chain. Oxygen will normally be present as oxo or oxy,
bonded to carbon and hydrogen, preferably bonded solely to
Garbon, while nitrogen will normally be present as amino,
bonded solely to carbon, or amido, while sulfur would be
analogous to oxygen.
Common functionalities in forming the covalent
bond between the linking group and the molecule to be
conjugated are alkylamine, amide, amidine, thioamide, urea,
thiourea, guanidine, and diazo.
Linking groups which find particular application
with conjugation to polypeptides are those involving carboxlyic
acids which may be used in conjunction with diimides, or as
mixed anhydrides with carbonate monesters or as active
carboxlyic esters e.g. N hydroxy succinimide or p-nitrophenyl.
Nitrogen analogs may be employed as imidoesters. Aldehydes
can be used to form imines under reductive amination conditions
e.g. in the presence of borohydrides, to produce alkylamines.
Other non-oxo carbonyl groups which may be employed include
2~ isocyanates and isothiocyana-tes. In addition, active halide
may be employed, particularly bromoacetyl groups.
In most instances, the ligand will have one or
more functional groups which may be employed as the site for
linking the linking group. Particularly, hydroxy, amino and
aryl groups, particularly activated aryl groups find use.
Also, oximes may be prepared from oxo functionalities and
the hydroxyl used as a site for joining to a linking group,
such as carboxymethyl.
The choice of linking ~roup will vary widely,
depending upon the functionalities which are present in the
,
~3~3~
43
ligand, in the compound to which the ligand is to ~e conju-
gated, the nature and length of the linking group desired,
and the like.
Solid Surface
The surace can be widely varied. Usually, the
surface will be chosen so as not to be strongly adsorbent for
members of the signal producing system, which would deleter~
iously affect the assay, so as not to interfere with the
measurement of the signal generated by the signal generating
s~stem and to substantially retains its physical integrity
during the assay. The surface may take different forms, have
different physical characteristics, can be of ~ifferent
chemical compositions and may be of one or more compositions
as a mixture of compositions or iamlnates or co~binations
thereof. The particular surface will interact with the
signal generating compound by desolubilization of the signal
generating compound onto the surface, or permi-t complexation,
reaction or interaction of a compound bonded to the surface,
so as to form or destroy the signal generating compound.
2~ The surface may be of a variety of shapes and
forms, as well as of varied dimensions depending on the
manner of use and measurement. The surface may be supported
by a rod, tube or capillary, fiber, strip, disk, plate,
cuvette, or the like. The surface will be an integral pa~t
of the support or distinct from the support as an applied
layer having a relatively small thickness, usually at least
0.1~, more usually 1~, generally 10~, or greater dependin~ on
the nature of the surface, ease of application and desired
properties.
The surface may be opaque, translucent or transpar-
ent. It may be a solid, gel or viscous liquid, permeable or
non-permeable, porous or non porous, bibulous, reticulated7
convoluted, channeled, being uneven or smooth, or coated with
a continuous or discontinuous layer. Preferably, the surface
will be penetrable by the signal generating compound to at
least a depth of 0.1~, more preferably at least 1~ and par~
ticularly preferred at least 10~.
~3~3~2
44
The surface may also be considered in accordance
with its function. The surface serves as a base or substrate
which will retain a discrete existence in the aqueous assay
solution, ~o as to be discernable from the medium and usually
S separable from the medium. The surface serves to support
mips which are bound to it, so that -they are incapable of
diffusing through the solution independent of the surface.
In addition, -the surface acts as a support for the signal
generating compound, either as a base for a deposi-ted lay~r
or as a support for covalent or non-covalent attachment. The
surface is effectively non-fluid, discrete in ~hat ~he sur~
face is distinguishable from the liquid medium in which the
surface is immersed, and provides a distinct base or founda~
tion for supporting mips, members o~ the signal generating
system or other compounds as appropriate, which are bound
either covalently or non-covalently. The surface may ex.ist
in a charged or non-charged form, being charged where such
charge provides some advantage to the operation of the signal
producing system.
Various materials may be employed, the primary
considerations being the binding of the signal generating
compound to the surface, the absence of interference of
signal generation, the ease of conjugating to the surface,
and the like.
A wide variety of organic and inorganic polymers,
both natural and synthetic may be employed as the material
for the solid surface. Illustrative polymers include poly-
ethylene, polypropylene, polyt4-methylbutene3, polystyrene,
polymethacrylate, poly~ethylene terephthalate), rayon, nylon,
poly(vinyl butyrate), silicones, polyformaldehyde, cellulose,
cellulose acetate, nitrocellulose, etc. Other`materials
which may be employed, include paper, glasses, ceramics,
metals, metalloids, semiconductive materials, cermets or the
like. In addition are included substances that form gels,
such as proteins e.g. gelatins, lipopolysaccharides,
silicates, agarose, and polyacrylamides or polymers which
form several aqueous phases, such as dextrans, polyalkylene
glycols (alkylene of 2 to 3 carbon atoms~ or surfactants e.g.
:,
3~
amphiphilic compounds, such as phospholipids, long chain
~12-24 carbon atoms~ alkyl ammonium salts and the like.
Where the solid surface is porous, various pore
sizes may be employed depending upon the nature of the
system. In some instances, the pore si~e may b~ limited, in
order to avoid access to catalyst bound to the surface.
Cut off sizes can vary from tens of thousands, e.g. 20,000 to
millions dalton, e.g. 20 million, usually cut-off size will
not be less than 5000 daltons.
The particular material employed for the solid
surface will be insoluble in the assay medium, may be swel-
lable or nonswellable, preferably nowswellable, may be
hydrophobic or hydrophilic,~i.e. polar or non-polar, prefer-
ably hydrophilic, may be coated with a thin mono- or pol~y-
molecular layer of a different composition or uncoated, may
be a single material or a plurality of materials, particular-
ly as laminates or fibers, may be woven, cast, extruded,
etched, aggregated, etc.
In preparing the surface, a plurality of different
materials may be employed, particularly as laminates, to
obtain various properties. For example, a porous layer may
be deposited onto a nonporous transparent cuvette wall, which
may provide a window for viewing ~he signal, while protecting
the adjacent layer. A surface may be modified so as to
enhance the hinding characteristics of the signal generating
compound, inhibit migration in a particular direction, act as
a semi-permeable membrane, or the like. Protein coatings,
e.g. gelatin can be employed to avoid non-specific binding,
simplify covalent conjugatlon, enhance signal detection or
~he like. However, it should be appreciated that the mater-
ial employed should preferably not be strongly adsor~ent, so
as to adsorb a ~ignal generating compound which is produced
in ~he bulk solution and diffuses to ~he surface.
The particular dimensions of the surface suppcrt
will be a matter of convenience, depending upon ~he size of
the samples involved, the protocol, the means for measuring
the signal, and ~he like.
~ 3~
46
The surface will usually be polyfunctional or be
capcible of being polyfunctionali~ed, so as to allow for
covalent bonding between the mip and the surface, as well as
the other compounds which must be conjugated. Functional
groups which may be present on the surface ~md used for
linking can include carboxylic acids, aldehydes, amino
groups, cyano groups, ethylenic groups, hydroxyl groups,
mercapto groups and the like. The manner of linking a wide
variety of compounds to the various surfaces is well known
and is amply illustxated in the literature. See for example
Immobilized Enzymes, Ichiro Chibata, Halsted Press, New York,
1978, and Cuatrecasas, J. Biol. Chem 245 3059 ~1970).
The length of the linking group may vary widely
depending upon the nature of the compound being linked, the
effect of the di.stance between the linked compound and the
surface on the linked compound's properties, the potential
for cross-linking of the linked compound, and the like.
The linkin~ group may be a bond or have up to about
12, usually not more than about 10 atoms in a chain. The
linking group may b~ aliphatic, alicyclic, aromatic,
heterocyclic, or combinations thereof. The total number of
atoms of the linking group will be not more than about 20,
usually not more than about 16 atoms other than hydrogen,
which will be carbon, oxygen as oxy or oxo, both o~co-carbonyl
ànd non-oxo-carbonyl; nitrogen as amino or amido, and sulfur
as thio or thiono. Illustrative groups include
methylenecarbonyl, succinimidyl, ~haloacetyl, thiomethylene,
glycyl or polyglycyl, succindioyl, maledioyl,
glutardlalkylidene, methylenephenyldiazo, and ureido.
A mip will always be bound, covalently or
non-covalently to the solid surface. Dependin~ upon the
nature of the protocol, the amount of bound mip may be
limited or in excess vf the highest amount of analyte which
can be expected to be found in the sample based on binding
sites of the analyt~. In addition, one or more me~ber~ of
the signal producing system may also be bound to the solid
surface. Frequently, the amount of ~he member of the signal
producing system which is conjugated will be rate limiting,
~o that large excesses will be employed.
-,.
~ .
.
`:
~7
Si~nal Producing System
The signal producing system has at least two
members: A catalysk, normally an enzyme; and a solute, which
is cap~ble of undergoing a catalyzed reaction which may
directly provide the signal generating compound, may provide
a precur60r to the signal generating compound, or may produce
a product which serves to react or interact with another
compound to produce, block or destroy the signal generating
compo~md .
As already indicated, one or a plurality of
catalysts may be employed, but usually at least one of the
catalysts will be an enzyme. ~hile there may be two or more
catalysts, usually as ~he number -o~f catalys-ts increases over
three, the advantages are quickly offset by the disadvan--
tages. Thereore, normally there will not ~e more than three
catalysts, usually not more than two catalysts.
At least one catalyst will he bound to a mip,
either covalently or non-covalently, for example through a
specific binding pair. One or a plurality of the same or
different catalyst molecules may be bonded to one or more
mips or alternatively, a plurality of mips may be bonded to a
single catalyst molecule. Where there are a plurality of
catalysts, the choice of which catalyst to bond to the solid
surface and/or the mip, will depend upon the conveniences
involved in formulating the reagents, ease of conjugation and
the effect on the sensitivity of the assay. Therefore, there
frequently will be a preference as to which catalysts are
conjugated to the solid surface and which catalysts are
conjugated to the mip.
To provide a siynal preferentially associated with
the ~urface as compared to the bulk solution, ~arious tech-
niques may be used. These techniques include: insolubiliæa-
tion of a signal generating compound; preferential production
of a signal generating compound at the surface with binding
to the surface; scavenging or inhibition of catalyst-bound-
mip in the bulk solution; scavenging of a catalyst, signal
~enerating compound or a precursor in the bulk solution with
the component of the signal producing system protected from
48
the scavenger at the suxface; and producing a compound at ~he
surface which interacts, including reacts, with a compound on
the surface. Not only can these various techni~ues be used
individually, but ~hey can also be combined with advantage.
In desolubiliza-tion to provide an insoluble signal
generating compound, a compound is catalytic:ally transformed
from a soluble form to an in~oluble form; fc,r a dye from a
leuco form ~o a colored form; for a fluorescer, from a non-
fluorescent compound to a fluorescent compound.
A large number of dyes exist which are predicated
on being modified to a colored form as they bind to a variety
of natural fabrics. The same type of modification can be
involved in the subject inventïon, where the dye can be
desolubilized catalytically, particularly enzymatically. The
desolubilization may involve oxidationj reduction, or hydrol-
ysis, particularly of water solubilizing groups, such as
organic and inorganic esters, e.g. phosphates, pyrophos-
phates, carboxylates, e.g. uronates, sulfates, and the like,
or ethers, such as glycosidyl ethers.
A wide variety of compounds can be modified so as
to enhance their hydrophobicity -lack of solubility in an
aqueous medium. The compolmds can then be further modified
to enhance their hydrophilicity e.g. substitution with water
solubilizing substituents which upon catalytic removal
results in a product which has gained signal generating
capability. For example, phenolic compounds can be esteri-
fied with organic or inorganic acids or etherified with
sugars. Amines can be acylated. Heterocycles can be
oxidized or reduced to enhance solubility or insolubility.
In each instance the reactant will be incapable of signal
generation, while the product will be capable of signal
generation or influencing signal generation.
Various compounds may be employed as solutes which
upon catalytic transformation, either in one or two steps,
results in an insoluble electroactive or changed molecule,
chromophore or fluorophore product as the signal generator.
In some instance~ a redox reaction may transform a
sol~ble compound having light absorption at short wavelengths
3~
49
to an insoluble compound absorbing light at substantially
longer wavelengths. When a commercially available sompound
which could otherwise be emp]oyed as a solute does not pro-
vide an insoluble product, such commercial:Ly available com-
pound could be modified in conven-tional ways by substitution
with hydrophobic groups, such as hydrocarbon, e.g. alkyl,
halo, e.g. chloro and bromo, cyano, nitro, ox combination~
thereof. Alternatively where the commercially available
compound is insoluble, and could fulfill the reguirements of
a signal generating compound, such commercially available
compound could be employed as a solute if substituted with a
catalytically removable group which confers water solub:ility
and which effects a substantial change in the electroactive,
chromophoric or fluoxophoric properties o the compound.
The subject invention also lends itself to employ
colored coupling products employed in photography. By em-
ploying a catalyst other than silver, as the catalyst-bound-
mip, with a substrate which can be activated to react with a
compound bound to the surface to produce a colored coupling
product, the signal producing system can parallel color
photography. For an excellent xeview and list of composi-
tions which may be employed in the subject invetion, see "The
Theory of the Photographic Process," 3rd ed. Edited by T. H.
James, The Macmillan Co., New York (1966) pages 383-396.
Of particular interest are such combinations as
substituted anilines, particularly .amino-substituted anilines
and phenols, particularly naphthols. Individual compounds
include a-benzoyl-3-{a-(4-carboxymethylphenoxy)acetamido]-
acetanilide; 1-phenyl-3-[3-(4-cyanomethylphenoxy)benzamido~-
5-pyrazalone; 1-[4-(3,5-dimethylphenoxy)phenyl3-3-(4-
aminoethoxy-3-methylbenzamido)~5-pyrazalone; and l-hydroxy-
N~[y-(2-tert.-amyl-4-carboxymethylphenoxy)propyl]-2~
naphthamide. These compounds can be covalently conjugated to
a surface or further modified with lipophilic groups to
become non covalently bound to a surface.
The following lists are compounds which may be
employed as solutes, which by one or two step catalytic
transformations would produce a ~ignal generating compound.
In some instances because of the solubility characteristics
of the compounds, some substitution would be necessary to
achieve the desired properties. The lis~ oi chromophores and
fluorophores is broken down into categories of the nature of
the listed reaction.
CHROMOPHORS AND FLUOROPHORE REACl'IONS
__
Redox
tetrazolium salt ~ formazan
leuco methylene blue ~ methylene blue
leuco Meldola blue ~ Meldola blue
4-Cl-l-naphthol -~ colored oxidation product
leuco phenazine methosulfate ~ phenazine methosulfate
N-3,5-dibromo or N-3,5-dichloro-4 hydroxyphenyl
~-dimethylaminoaniline -~ N~ dimethylaminophenyl)
3,5-dibromo- or 3,5-dichloroquinone monoimine
dihydropyocyanine ~ pyocyanine
2-(2'-benzothiazolyl)~5-styryl-3~(4'-phthalhydrazidyl)
tetrazolium chloride ~ formazan derivative
dihydrosafranine ~ safranine
leuco benzyl viologen ~ benzyl viologen
diaminobenzidine ~ colored oxidation products
o-toluidine -~ colored oxidation product
a naphthol ~ pyronine -~ fluorescent product
5 amino-2,3-dihydro 1,4-phthalazinedione ~ hv
aminoantipyrene ~ 1,7-hydroxynaphthol -~ colored
coupling product
~is
umbelliferyl phosphate ~ umbelliferone
~,4-dinitronaphthyl-1 ~-D-galactoside -~ ~,4-dinitronaphthol
3~
N-(2'-methoxyphenyl) 6-bromo~3-carboxamide-naphthyl~
~-D-glucosiduronic acid ether ~ N-~2'~metho~yphenyl)
6~bromo-3-carbo~amide-2 naphthol
water soluble
The preferred spectrophotometrica].ly active com-
pounds - dyes, fluorescers and chemiluminescers- have hydroxyl
groups, particularly one or more phenolic groups, which are
present in the parent compound or may be int;roduced. The
hydroxyl groups are convenient sites for esterification to
form e~ters e.g. phosphates and uronate~ or ethers, particu-
larly glycosidyl ethers.
As already indicated, both enzymatic and nonenzy-
matic catalysts may be employed. Preferably,-enzymatic
catalysts will be employed, since they frequently provide for
more rapid reactions, a-desirable versatility in the variety
of reactions, and have well characterized properties.
In choosing an enzyme, there will be many consid-
erations in addition to those involved with the reaction of
interest. These considerations include the stability of the
enzyme, the desirability of a high turnover rate, the sensi-
tivity of the rate to variations in the physical environment,
the nature of the substrate~s) and product~s~, the avail-
ability of the enzyme, the effect of con~ugation of the
enzyme on ~he enzyme's properties, the effect ~n enzyme
activity of materials which may be encountered in the sample
~olutions, the molecular weight of the enzyme, and ~he like.
The ollowing are categories of enzymes as set
forth in accordance with the classification of the Inter-
national Union of Biochemistry.
3~
52
ABLE II
1. Oxiodoreductases
1.1 Acting on the CH-OH group of dono:rs
1.1.1 With NAD or NADP as acceptor
1.1.2 With a cytochrome as an acceptor
1.1.3 With 2 as acceptor
1.1.99 With other acceptors
1.2 Acting on the aldehyde or keto group of donors
1.2.1 With NAD or NADP as acceptor
1.2.2 With cytochrome ~s an acceptor
1.2.3 Wi~h O~ as acceptor
1.2.4 With lipoate as acceptor
1.2.99 With other acceptors
1.3 Acting on the CH-CH yroup of donors
1.3.1 With NAD or NADP as acceptors
1.3.2 With a cytochrome as an acceptor
1.3.3 With 2 as acceptor
1.3.99 With other acceptors
1.4 Acting on the CH-NH2 group of donors
1.4.1 With ~D or NADP as acceptor
1.~.3 With 2 as acceptor
1.5 Acting on the G-NH group of donors ~ :
1.5.1 with NAD or NADP as acceptor
1.5.3 With 2 as acceptor
1.6 Acting on reduced NAD or NADP as donor
1.6.1 With NAD or NADP as acceptor
1.6.2 With a cytochrome as an acceptor
1.6.4 With a disulfide compound as acceptor
1.6.5 With a quinone or related compound
as acceptox
1.6.6 With a nitrogeneou~ group as acceptor
1.6.99 With other acceptors
1.7 Acting on other ~itrogeneous compounds as donors
1.7.3 With O~ as acceptor
1.7.99 With other acceptors
1.8 Acting on sulfur groups of donors
1.8.1 With NAD or NADP as acceptor
1.8.3 With 2 as acceptor
~; ' ' "' ' '' :
' i
'
'
53
1.8.4 With a disulfide compound as acceptor
1.8.5 Wi~h a guinone or related compound
as acceptor
1.8.6 Wi~h nitrogeneous group as acceptor
l.9 Acting on heme groups of donors
1.9.3 With 2 as acceptor
1.9.6 With a nitrogeneous group as acceptor
1.10 Actiny on diphenols and related s~stances
as donors
1.10.3 With 2 as ac~eptors
l.ll Acting on H2O2 as acceptor
1.12 Acting on hydrogen as donor
1.13 Acting on single donors with incorporation of
oxygen (oxygenases)
1.14 Acting on paired donors with incorporation of
oxygen into one donor (hydroxylases~
1.14.1 Using reduced NAD or NADP as one donor
1O14.~ Using ascorbate as one donor
1.14.3 Using reduced pteridine as one donor
2. Transferases
2.1 Transferring one-carbon group~s
2.1.1 Methyltransferases
2.1.2 -Hydroxymethyl-, ormyl- and related
transferases
2.1.3 Carboxyl- and carbamoyltransferases
2~ Amidinotransferases
2.2 Transferring aldehydic or ketonic residues
2.3 Acyltransferases
2.3.1 Acyltran6ferases
2.3.2 Aminoacyltransferases
2.4 Glycosyltransferases
2.4.1 Hexosyltransf~rases
2.4.2 Pentosyltransferases
2.5 Transfexring alkyl or related groups
2.6 Transferring nitrogenous groups
2.6.1 Aminotransferases
2.6.3 Oximinotransferases
.~ .
3;~
5~L
2 . 7 Transferring phosphorus~containing groups
2.7.1 Phosphotransferases with an alcohol
group as acceptor
2.7.2 Phosphotransferases with a carboxyl
group as acceptor
2.7.3 ~hosphotransferases with a nitrogeneous
group as acceptor
2.7.4 Phosphotrans*erases with a phospho-
group as acceptor
2.7.5 Phosphotransferases, apparently
intromolecular
2.7.6 Pyrophosphotranserases
2.7.7 . Nucleotidyltr`ansferases
2.7.8 Transferases for.other sl~stituted
phospho-groups
2.8 Transferring sulfur-containing groups
2.8.1 Sulfurtransferases
2.8.2 Sulfotransferases
2.8.3 CoA-transferases
3. Hydrolases
3.1 Acting on ester bonds
3.1.1 Carboxylic ester hydrolases
3.1.2 Thiolester hydrolases
3.1.3 Phosphoric monoester hydrolases ~ :
3.1.4 Phosphoric diester hydrolases -
3.1.5 Triphosphoric monoester hydrolases
3.1.6 Sulfuric ester hydrolases
3.2 Acting on glycosyl compounds
3.2.1 Glycoside hydrolases
3.2.2 ~ydrolyzing N-glycosyl compounds
3.2.3 Hydrolizing S-glycosyl compounds
3.3 Acting on ether bonds
3.3.1 Thioether hydrolases
3.4 Acting on peptide bonds (peptide hydrolases)
3.4.1 a~Aminoacyl-peptide hydrola~es
3.4.2 Peptidyl-aminoacid hydrolases
3.4.3 Dipeptide hydrolases
3.4.4 Peptidyl-peptide hydrolases
,1.
. ' :
.
3.5 Acting on C-N bonds other than peptide bonds
3~5.1 In linear amides
3.5.2 In cyclic amides
3.5.3 In linear amidines
S 3.5.4 In cyclic amidines
3.5.5 In cyanides
3.5.99 In other compounds
3.6 Acting on acid-anhydride bonds
3.6.1 In phosphoryl~containinc3 anhydrides
3.7 Acting on C-C bonds
3.7.1 In ketonic substances
3.3 Acting on halide bonds
3.8.1 In-C~halide compounds
3.8.2 In P-halide compounds
3.9 Acting on P-N bonds :
4. Lyases
4.1 Carbon-carbon lyases
4.1.1 Carboxy-lyases
4.1.2 Aldehyde~lyases
4.1.3 Ketoacid-ly~ses
4.2 Carbon-oxygen lyases
4.2.1 Hydro-lyases
4.2.99 Other carbon-oxygen lyases
4.3 Carbon-nitrogen lyases
4.3.1 ~mmonia-lyases
4.3.2 Amidine lyases
4.4 Carbon-sulfur lyases
4.5 Carbon-halide lyases
4.99 Other lyases
5. Isomerases
5.1 Racemases and epimerases
5.1.1 Acting on amino acids and derivatives
5.1.2 Acting on hydroxy acids and
derivatives
5.1.3 Acting on carbohydrates and
derivatives
5.1.99 Acting on other compounds
5.2 Cis-trans isomeras~s
,
~l3~3~
5~
5.3 Intramolecular oxidoreductases
5.3.1 Interconverting aldoses and ketoses
5.3.2 Interconverting keto ancl enol groups
5.3.3 Transposing C-C bonds
5.4 Intramolecular transferases
5.4.1 Transferring acyl groups
5.4.2 Transferring phosphoryl groups
5.4.99 Transferring other groups
5.5 Intramolecular lyases
5.99 Other isomerases
6. Ligases or Synthetases
6.1 Forming C~O bonds
6.1.1 Aminoacid~RNA ligases
6.2 Forming C-S bonds
6.2~1 Acid-thiol ligases
6.3 Forming C-N bonds
6.3.1 Acid-ammonia ligases (c~mide
synthetases)
6.3.2 Acid-aminoacid ligases (peptide
synthetases)
6.3.3 Cylo~ligases
6.3.4 Other C-N lig~ses
6.3.5 C-N ligases with glutamine as
N-do~or
6.4 Forming C-C bonds
Of particular interést will be enzymes which are in
Class 1. Oxidoreductases and Class 3 hyrdolases, although
enzymes of Class 2, Transferases, Class 4 Lyases and Class 5,
Isomerases, can also be of interest in particular situatio~s.
The foll~wing table has specific subclasses of
enzymes and specific enzymes within the subclass which are of
particular interest. Among the oxidoreductases, -those in-
volving NAD or NADP, oxygen or hydrogen peroxide are of
particular interest. Among the hydrolases, those in~olving
phosphate and glycosides are of particular interest.
.
`3;~
TABLE III
1. Oxidoreductases
1.1 Acting on the CH-OH group of donors
1.1.1 With NAD or NADP as acceptox
1. alcohol dehydrogenase
6. glycerol dehydrogen~se
27. lactate dehydrogenase
37. malate dehydrogenase
49. glucose-6-phosphate dehydrogenase
1.1.3 With 2 as acceptor
4. glucose oxidase
galactose oxidase
1.2 Acting on the aldehyde or keto group o~ donors
1.2.1 With NAD or NA~P as acceptor
lS 12. . glyceraldehyde-3-phosphate
dehydrogenase .
1.2.3 With 2 as acceptor
2. xanthine oxidase
luciferase
1.4 Acting on the CH-NH2 group of dcnors
1.4.3 With 2 as acceptor
2. L-amino acid oxidase
3. D-amino acid oxidase
1.6 Acting on .reduced NAD or ~ADP as donor
1.6.99 With other acceptors
diaphorase
1.7 Acting on other nitrogeneous compou.nds as donors
1.7.3 With 2 as acceptor
3. Uricase
1.11 Acting on H2O2 as acceptor
1.11.1
6. catalase
7. peroxidase
2. Transferases
2.7 Transferring phosphorus--containing groups
2.7~1 Phosphotransferases with CH~OH
as acceptor
l. hexokin~se
`3~
58
2. glucokinase
15. ribokinase
28. triokinase
40. pyruvate kinase
52.7.5 1. phosphoglucomutase
3. Hydrolases
3.1 Acting on ester bonds
3.1.1 Carboxyllc ester hydrolases
7. cholinesterase
8. psuedo cholinesterase
3.1.3 Phosphoric monoester hydrolases
1. alkaline phosphatase
2. acid'phosphat:ase
9. glucose~'6-phosphatase
11. fructose diphosphatase
3.1.4 Phosphoric diester hydrolases
l. phosphodiesterase
3. phospholipase C
3.2 Acting on glycosyl compounds
203O2.1 Glycoside hydrolases
1. alpha amylase
2. beta amylase
4. cellulase
17. muramidase
18. neuraminidase
21. beta g:Lucosidase
23. beta galactosidase
31. beta glucuronidase
3~. hyaluronidase
303.~.2 ~ydroly2ing N-glycosyl compounds
5. DPNase
4. Lyases
4.1 Carbon carbon lyases
4.1.2 Aldehyde lyases
13. aldolyase
4.2.1 ~ydro-lyases
1. carbonic anhydrase
~3~
59
5. Isomerase
5.4 Intramolecular transferases
5.4.2 Transferring phosphoryl group
trio~e phosphate isomerase
Nonen~ymatic catalysts may also find use, but will
normally no-t be employed by themselves, but in conjunction
with an enzymatic catalyst. Therefore, their use will be
discussed in conjunction with the preferential production of
the signal generating compound at the solid surface.
Of particular interest in the subject invention is
the use of coupled catalysts, usually two or more enzymes,
where the product of one enzyme serves as the substrate of
the oth~r enzyme. One or more en2ymes are bound to the
surface, while one enzyme is always bou~d to a mip. Alterna-
tively, two enzymes can be hound to a mip, with or without an
additional enzyme bound to the surface. The solute will be
the substrate of any one of the enzymes, but preferably of an
enzyme bound to the surface. The en2ymatic reaction may
involve modifying the solute to a product which is the sub-
strate of another enzyme or production of a compound whichdoes not include a substantial portion of the ~olute, which
serves as an enz~me substrate. The first situation may be
illustrated by glucose-6-phosphate being catalytically
hydrolyæed by alkaline phosphatase to glucose, wherein
glucose is a substrate for glucose oxidase. The second
situation m~y be illustrated by glucose being oxidized hy
glucose oxidase to provide hydrogen peroxide which would
enzymatically react with the si~nal generator precursor to
produce the signal generator.
Coupled catalysts can al60 involve an enzyme with a
non-enzymatic catalyst. The enz~me can produce a reactant
which undergoes a reaction catalyzed by the non~enz~matic
catalyst or the non~enzymatic catalyst may produce a sub-
strate (includes coen~ymes) for the enzyme. For example,
Meldola blue could catalyze the conversion of NAD and hydro-
quinones to NADH which reacts with FMN o~idoreductase a~d
bacterial luciferase in the presence of long chain aldehydes
to produce light.
.
A wide variety of nonenæymatic catalysts which may
be employed in this invention are found in U.S. patent
~,160,645l issued July 10, 1979. The nonenzymatic catalysts
employ as reactants a first compound which reacts by a 1-
electron transfer and a second compound which reacts by a 2-
electron transfer, where the two reactants are capable of
reacting with each other slowly, if at all, in the absence
of the catalyst.
Various combinations of enzymes may be employed -to
provide a signal generating compound at the surface. Par-
ticularly, combinations of hydrolases may be employed to
produce an insoluble signal generator. A single exohydrol-
ase may act in a substantially equivalent manner to an
enzyme pair by employing the appropriate substrate. Alter-
natively, combinations oE hydrolases and oxidoreductases canprovide the signal generator. Also, combinations of oxidore-
ductases may be used to produce an insoluble signal generator.
The following table is illustrative of various combinations
which may be employed to provide for preferential production
of the signal generating compound at the surface. Usually
there will be a preferred catalyst at the surface since,
as indicated previously, by appropriate ~hoice of the
catalyst at the surface, a greater number or reagents may be
combined in a sing]e formation
In the following table the first enzyme is intended
to be bound to the surface and the second enzyme to a mip,
although in particular situations it may be desirable to
reverse their positions.
~ ,
- -
,~
~ .
61
INTERRELATED TWO ENZYME SYSTEMS
First Second Signal
Enzyme ~ Solute GeneratiQn
-
~. Galactose horse radish ~-D-galactose 4-Cl-1-
5oxidase peroxidase naphthol dye
2. uricase horse radish urate o-dianisidine
peroxidase dye
3. glucose microper- ~-D glucose bis-toluidine
oxidase oxidase . dye
4. esterase ~-glucur- 2,2-bis(3'- 3',3"-clichloro-
onidase chloro- phenolphthalein
4'-glucurony-
loxyphenyl)
phthalide
choline
chloride ester
5. alkaline peroxidase 4-Cl-1- 4-Cl-l-
phosphatase naphthyl naphthol dye
phosphate
20 6. hexokinase glucose-6- glucose iodonitro-
phosphate triphenyl
dehydrogenase formazan
7. alkaline ~-galactosi- o7 - ( ~-D-gal- 4-alkylum-
phosphatase dase actosidyl-6'- belliferone
phosphate)
4-alkylumbel-
liferone
~3~
~2
INTERRELATED TWO ENZYME SYSTEMS-continued
First
Enzyme __ Reactlons
1. Galactose 1. galactose ~ 2 ~ D-galactono-~-lactone
5oxidase 2 2
2. H2O2 ~ ~~Cl-l-naphthol ~ dye
2. uricase 1. urate + 2 ~ allantoin ~ H202
2. ~22 ~ o-dianisidine -~ dye
3. glucose 1. glucose ~ 2 ~ D-glucono-~-lactone
10oxidase . ~2Q2
2. H2O2 +`bis-toluidine ~ dye
.
4. esterase 1. 2,2~bis~3'-chloro-4'-glucuronyloxyphenyl)
phthalide choline chloride ~ 2,2-bis
(3'-chloro-4'-~lucuronyloxyphenyl)-
phthalide
2~ 2,2-bis(3'-chloro-4'-glucuxonyloxy-
phenyl3phthalide ~ 3',3"~dichloro-
phenolphthalein
5. alkaline 1. 4-Cl-l-naphthyl phosphate ~ 4 Cl-l-
20phosphatase naphthol
2. 4-Cl-l-naphthol ~ dye
6. hexokinase 1.. glucose ~ ATP ~ glucose-6-phosphate
2. glucose-6-phosphate + NADP ~ NADPH
phenazine methosulfate ~ N~DPH -~
triphenyltetrazolium chloride -~ formazan
7. alkaline 1. o7-~ D-galactosidyl-6'-phosphate)-
phosphatase 4-alkylumbelliferone ~ o7~ D-
galactosidyl) 4-alkylumbelliferoIle
2 . o7 - ~ ~-D-galactosidyl) 4-alkylumbel~
liferone ~ 4-alkyl~mbelliferone
., : " -,' ,
~3~3~
63
INTERRELATE:D ENZYME AND NON-ENZYMATI C CATALYST SYSTEMS
Enzyme on Signal
mip Catal~st Solute eneration
1. G-6-PDH Meldola N.AD formazan
blue
2. lactate phenazine NAD benzyl-violo-
dehydrogen- methosulfate gen dye
ase
3. 3-hydroxy pyocyanine NAD forma2an
butyrate
dehydro-
genase
Precursor to signal generator may be covalently bonded to
solid surface.
INTERRELATED ENZYME AND NON-ENZYMATIC CATALYST SYSTEMS
continued
Enz~me on
~ æ___ Reactions
1. G-6~PDH 1. G-6-P + NAD ~ glucuronate-6-P + NADH
2. NADH ~ triphenyltetrazolium ~ NAD
formaxan
2. lactate l. lactate + NAD ~ pyruvate + NADH
dehydrogen- 2. NADH -~ ben~yl violoyen ~ NAD + dye
a~e
25 3. 3-hydroxy 1. 3-hydrox~butyrate + NAD ~ acetoacetate
butyrate + NADH
dehydro- 2. NAD~ + triphenyltetrazolium ~ NAD +
genase 0rma2an
64
Quite obviously, many of the dyes indicated above
may be substituted with other dyes which have the proper
solubility requirements or which can be modified to have the
proper solubility requirements for the subject invention. In
addition, it should be appreciated, that by having a high
localized concentration of the dye, the dye will rapidly bind
to the surface. In addition, any incremental amount of dye
which diffuses from the bulk solution to the surface will not
significantly affect the amount of dye which precipitates on
the surface. Depending upon the nature of the dye, ei~her
light absorption by the dye or, if fluorescent, light emis-
sion may be measured. Instead of dyes, electroactive com-
pounds may be produced and electrical properties at the
surface measured.
Instead of a chemical react.ion of an enzyme product
to produce the signal generating compound, the environment of
the enzyme product can be selectively modified, upon binding
to the surface, 50 as to produce the signal generating com-
pound. For example, one could hydrolyze an ester or ether to
produce an insoluble colorless form of a p~ sensitive dye at
the surface. The local pH at the surface will be made sub-
stantially different from the bulk solution by having changed
groups on the surface. By employing a signal genexating
compo~md which is sensitive to proton concentration, the
observed signal from the product bound to the surface would
differ greatly from the product in the bulk solution or
liguid phase. Fluorescer quencher pairs may also be employed
where the solute produces an insoluble quencher molecule,
which binds to the surface. Increasing amounts of the
quencher molecule on the surface will result in substantially
decreased fluorescence from the fluorescent mQlecules bonded
to the surface.
Besides acid-base effects and fluorescex and
quencher pairs, other interactions may include enzyme
i~hibitor~enzyme combinations, medium effects caused by
hydrophobic binding, redox reactions, covalent coupling to
form surface bound dyes, or the like.
:, :
'' " ' ~
.
`3~
One can further enhance the differentiation between
the concentration of -the signal generator at the solid sur-
face as compared to the signal generator in the solution, by
having a scavenger for a member of the signal producing
system. The role ~f the scavenger is to int:eract with a
component of the signal producing system to inhibit the
functioning of the component in the production of the detect-
ible signal. The scavenger employed can act: in a variety of
ways.
The first way is -to employ a scavenger for the
signal generator which interacts with the signal generator to
inhibit its formation of a signal. This inhibition can be as
a result of a chemical reaction or specific or nonspecific
binding. So far as a chemical reaction, a wide variety of
chemical reactions can be employed depending upon the nature
of the signal generator. For example, if the dye goes from a
leuco to a colored form by virtue of an oxidation-reduction
reaction, by providing fox reversing the reaction in the bulk
solution, the colored ~orm can be substanti.ally minimized in
the bulk solution. The chemical scavenger employed should
either react with the signal generator on the surface ex-
tremely slowly or not at all. Convenient scavenger~ would be
enzymes which would reverse the redox reaction or antibodies
which would modify the absorption or emission characteristics
of a dye. Enzymes or antibodies could be employed which are
monomeric or pol~meric e.g. bound to particles, so as to
reduce their ability to interact with the si~nal generator on
the surface.
Instead of scavengers for the signal generator, one
may employ a scavenger for a different member or intermediate
of the signal generating system. One can utilize the steric
bulk of the surface to discriminate between càtalyst bound to
the surface and catalyst in -the bulk solution. By employing
inhibitory antienzyme bound to particles, en~ymes in the bulk
solution would be inhibited from reacting when the antien~yme
bound to the enzyme, while the enzyme bound to the surface
would be free to react. Similarly, one could provide other
inhibitors bound to particles wi-th which the enzyme reacts
resulting in destruction o the enzyme activity.
~3~3~
66
Where two enæymes are involved so that an inter-
mediate product is involved, one could employ as the scaveng-
er a reactant which destroys the intermediate. For example,
where an .intermediate product is hydrogen pleroxide, by adding
catalase, the hydrogen peroxide would be destroyed in the
bulk solution. At the surace, however, thlere would be more
efective competition by the relatively concentrated catalyst
bound to the surface with ~he catalase for the hydrogen
peroxide. This competition could be made even more favorable
by attaching the catalase to particles that are sterically
excluded from the surface. With different systems, different
technigues can be employed, using the versatility of the
subject system to achieve the desired effect.
Finally, one can provide:for-a compound bonded to
the surface which will interact with a product o the cata-
lyzed reaction. For example, one can produce a compound
which will react with the compound on the surface to change
the compound rom the leuco form to the colored form. Illus-
trative of such a technique would be to oxidize NAD~ with a
nonenzymatic catalyst and a tetrazolium salt bonded to the
surface. The catalyst could be, for example, phenazine
methosulfate or Meldola Blue. The NAD~ would react with the
catalyst which would promptly react with the tetrazolium salt
on the surface to form the dye. One could conveniently
couple this with a scavenger, such as an oxidant which
reoxidized the reduced catalyst, so that any reduced catalyst
which was formed in the bulk solution would be rapidly
destroyed. A significant alternative would be, for example,
1,7-naphthalenediol bound to the surface which captures
aminoantipyrene oxidation product produced by HRP. Less
chromogenic nucleophiles could act as scavengers.
The next element of the signal producing system is
the solute. The solute will be the initial reactant subject
to catalytic transformation to a product. As already diso
cussed, the product can play a number of different roles.
The product may be the signal generator which becomes bound
to the solid surace. Alternatively, the product may be an
intermediate which serves as a substrate for a second
.
~31~3%
67
catalyst, which further transforms the product to provide the
signal generator. Alternatively, the solute can undergo a
reaction which leads to a compound which then react~ with
~nother compound to produce the signal geneI-a-tor. The other
compound may be free in solution or bound to the solid sur~
face, with the reaction being either catalyzed or
uncatalyzed.
Ancillary Materials
Various ancillary materials will i-re~uently be
employed in the subject assays. Particularly, en~yme sub-
strates, cofactors, ~ctivators, scavengers, inhibitors or the
like may be included in the assay medium.
In addition, buffers will narmally be present, as
well as stabilizers. Frequently in addition to these addi-
tives, additional proteins may be included, such as albumins;or surfactants, particularly non-ionic surfactants, e.g.
polyalkylene glycols, or the like.
Compositions
Novel compositions and solid test films or strips
are provided, as well as combinations of reagents for use in
the determination of a wide variety of analytes. Of particu-
lar interest are haptens having physiologic activity, coval-
ently bonded to a solid porous support to which is also
covalently ~onded an enzyme, particularly a redox enzyme or a
hydrolase. The solid supports are used in conjunction with a
receptor to which is bonded an enzyme, where the enzyme-
bound-receptor employs the product of the enzyme-bound~solid
support as a substrate. Included with the enzyme-bound-
receptor is the suhstrate for the enzyme-bound solid support.
Impregnated in the solid support may be buffers, s~strates
and cofactors for the enzyme on the solid supp~ort othex than
the substrate or cofactor combined with the enzyme-bound-
receptor. The amQUnts of the various reagents are optimized
to enhance the sensitivity of the assay for the analyte.
For an antigenic analyte, either the receptor ~or
the antigen or the antigen may be covalently bonded to the
solid support along wi~h an enzyme. The solid support con-
taining the receptor or antigen and the enzyme is analogous
to the solid support with ~he hapten.
68
Alternatively, a solid support can be employed
haviny a mono- or polyepitopic antigen or receptor bound to
it in conjunction with a covalently bonded electrophilic or
nucleophilic coupler. The coupler can react wi~h its appro-
priate partner. For example, with a nucleophilic couplerbound to the support, oxidized forms of developers, such as
aromatic amines may be employed as coupling partners to form
dyes. The reduced form of the dye may be used as the solute
in conjunction with an enzyme-bound-mip, where the enzyme is
lQ an oxidoreductase, such as peroxidase. The peroxidase will
oxidize the reduced form of the developer e.g. aromatic
amine, which will react with the coupling agent on the sup-
port to produce a dye. Illustrative coupling agents include
phenols, ~-diketones, pyrazalones, and the like.
Finally, a solid support can he employed having a
hapten, antigen or antibody in conjunction with a compound
covalently bonde~ to the solid support which can react with
-the reduced form of Medola Blue, phenazine methosulfate or
methylene blue to go from a leuco form to a colored form.
The strips will be used in conjunction with the oxidized form
of the aforementioned reductants, an enzyme-antibody conju~
gate, where the enzyme desirably produces NADH or NADP~ or
other reductant which will react with the aforementioned
catalytic reductants, which in turn will react with the lèuco5 form of the dye on the solid support.
EXPERIMENTAL
The following examples are offered by way of illus-
tration and not by way of limitation.
All percents and parts not o~herwise indicated are
by weight, except for mixtures of liquids which are by
volume. When a solvent is not indicated, water is intended.
All temperatures no-t otherwise indica-ted are centigrade. The
following abbreviations are employed:
C~M-03-carboxymethyl morphine; HRP-horse radish
peroxidase; NHS-N-hydroxy succinimide; EDCI-N-ethyl
N'-(3-dimethylaminopropyl) carbodiimide; DMF-N,N-dimethyl
formamide; THF~tetrahydrofuran; BSA-bovine ~erum albumin;
HIgG-human immunoglobulin G; THC-tetrahydrocannabinol
derivative; RT-room temperature; G0-glucose o~ida~e.
3~
69
Ex. 1. Morphine Horseradish Peroxidase
(~RP) ~onju~ate _ __
Into a reaction flask was combined lO~moles
O -carboxymethylmorphine, ll~moles of N-hydroxy succinimide
and 12~moles of EDCI in a to~al volume of about l~.lml in
DMF. After combining ~he reagents, the mixture was flushed
with nitrogen and stirred overnight in a co:Ld room. To 0.5ml
HR~ ~2mg) in 50mM agueous sodium carbonate l~p~9.5) was added
150ml DMF, followed by 300~1 of the above ester solution and
the mixture allowed to stand overnight at 4. The reaction
mixture was then applied to a 2x30cm column of G50 Sephaclex
and eluted with 0.05M tris, pH7O6, 0.lM KCl and the protein
monitored. The fractions in the void volume were pooled to
provide 0.5ml having a concentration of 0.2mg/ml. By employ-
ing a radioactive tracer, the morphine/HRP molar ratio wasfound to be 1.86 with a concentration of HRP of 200~g/ml.
Ex. 2. Protein Couplin~ to Paper Filter
Disk~Morphine
The following is -the exemplary protocol employed
for protein coupling to a paper support. Whatman #2 filter
paper disks 7cm dia. were activated in O.lM sodium periodate
for 5hrs. at room temperature. After washi~g with water
extensively, and drying in THF, lml of the apprvpriate
protein solution in 0.2M borate, pH8.5, 0.5M NaCl, O.lM
NaBH3CN was added to the disks and the mixture allowed to
stand overnight at 4. To the mixture was -then added 1.4ml
50mM Bicine buffer, pH8.5, containing 2mg NaBH4 and the
mixture allowed to stand for 3hrs. at room temperature,
followed by termination by washing the disks in lM borate,
pH8.5, 50mM Bicine, 0.2M KCl. The wash was about 20ml and
the protein in the wash was determined, with the amount of
protein bound to the disk determined by the difference.
The following table indicates the different protein
solutions employed and the concentr~tion of protein on
various d1sks in ~g/cm2.
3~
TABLE IV
Total Protein
Protein in Coupled to disc
1.5ml of Solution1 ~g/cm2
lOmg Ab~ 24.3
lOmg Ab~, 5A28oG0 45.6
5mg AbM~ 5A~8oG0 6.53
Y ~IgG' 5A280~ 7.39
g ~(RIg)' 280 8.69
0 ~ AbM ~ antibody to morphine
5A28oGO - glucose oxidase at a concentration having an
absorption of 5 at A280nm per cm
AbHIgG ~ antibody to human ~-globulin G
AbG(RIg) ~ antibody to rabbit r-globulin G from goat
antisera
In order to d~monstrate the subject invention, a
number of determinations were carried out to determine the ~.
effect of having ligand analyte present in ~he assay medium.
The following sample solutions were prepared. The
disk is indicated by the particular protein(~) bound to the
paper.
TABLE V
HRP-M2 CMM3RIg-HRP4 RIg5
# aperl ,ul ~ ~ ,ul
2$ 1. AbM 30 0 -
2. AbM 30 0
3. Ab~ 30 30
4. AbM 30 30 - -
5. AbMGO(2:1) 30 0 - -
6. AbMGO(2:1) 30 0 - -
7. ~bMG0~2:13 30 30 - -
8. Ab~GO(2:13 30 30
,
.
`3;~
71
TABLE V
~ continued )
HRP-M2C~3 RIg~~RP4 RIg5
Paper~
9 AbGARGO - ~ 4~
10 AbGARG0 ~ ~ 44
11 Ab~ARG0 4 10
12- AbG~R&O ~ ~ 44 10
1 Whatman filter paper (~6mm dia)
AbM ~ morphine antisera (-~6.08 ~gAb per disk)
AbMGO(2:1) - morphine antlse`ra plus glucose oxidase
2:1 mole ratio in reaction medium
(7.6,ugAb per disc)
AbGARGO - goat anti(rabbit IgG) plus glucose oxidase
1:1 mole ratio in xeaction medium
(~2.2~gAb per disk)
2 ~RP~M - morphine conjugated to horse radish peroxidase
and product diluted (20yg/ml~
3 CMM - 03-carboxymethyl morphine (90~g/ml)
2 4 Rig-HRP - rabbit immunoglobulin G conjugated to horse
radish peroxidase (13.8~gAb/ml)
RAb~IgG - rabbit immunoglobulin ~ ~
The protocol was as follows. The disk and CMM or
RIg were combined employing 0.94~1 of buffer, the buffer
being 50mM tris, pH7.6, lOOmM KCl, and 0.lmg/ml BSA. The
mixture was incubated for 5hrs followed by the addition of
HRP-M or RIg-H*P in lml of the appropriate reaction buffer to
~he incubation buffer or the disk was removed from the incu-
bation buffer, washed wi~h lml of water, and then combined
with the HRP-M or RIg~HRP in the reaction buffer. Depending
upon whether glucose oxidase was pxesent on the paper, the
reaction buffers differed in that in the absence vf glucose
oxidase, 20~1 of 90mM hydrogen peroxide was added in addition
to sufficient o-dianisidine to provide 0.lmg/ml. In the
presence of glucose oxidase, the buffer was made 50mM in
glucose and no hydrogPn peroxide was added.
. ~ ':
... : :
: : : . . . :.
~.~.3~
72
The odd number examples were carried out retaining
the disk in the incubation buffer and adding reaction buffer,
while the even number~d examples were carried out with -~he
removal of the disk from the incubation buffer, and washing
5 and then combining the disk and reaction buffer.
In each case, lml of the reaction buffer was
employed, and in the odd numbered examples, a 60min incuba-
tion was employed. In the Exs. 1, 3, 5, and 7, 20~1 of
3.9mg/ml catalase (30,000U/mg3 was also included, while in
Exs. 9 and 11 only 10~1 of the catalase solution was
included. In the even numbered examples, no catalase was
added.
In each of Exs. 1, 5, and 9, the disks were darker
than the comparable Exs. 3,-7, and 11 respectively, showing
that the presence of a ligand did allow for dis~rimination in
result.
In the even numbered assays, the reactions for 2,
4, 6 and 8 were carried out for 5mins, while for 10 and 12,
lOmins. The results were far more dramatic with the even
numbered examples, where the disk was clearly white in the
presence of the ligand and a dark brown in the absence of the
ligand.
The results clearly demonstrate that one can assay
for a ligand, both haptenic and antigenic, or a receptor,~by
employing a catalyst bound to a mip, which becomes distrib-
uted between a surface and the bulk assay medium in propor-
tion to the amount of ligand or receptor present in the
medium. In the subject situation, an insoluble signal gener~
ator is produced which becomes bound to the surface and
allows for measurement of the signal in relation to the
amount of analyte in the assay medium.
In the next study, the effect on the amount of
signal genera-tor produced in relation to varying concentra-
tions of analyte was evaluated. In effect, a standard curve
was prepared, relating the signal generator produced on the
surface to the amount of analyte in the medium. The protocol
was as follows.
3~
To tubes containing 500~1 bufer (50mM tris, pH7.6,
200mM KCl, 2mg/ml BSA), was added 20~l1 of the ~ -morphine
conjugate (0.2~g) followed by 20~1 of a
O -carboxymethylmorphine solution at varying concentrations.
To the tube ~as then added a 6mm disk of ~b~GO (2.1) and the
mixture incubated a-t 3hrs at room temperature.
The disk was then developed in three different
ways. In the first way, the supernatant was removed from the
disk, lml buffer added and removed. Then, lml of the devel~
opment buffer (lOOmM phosphate, p~6.0, 200mM KCl, O.lmg/ml
o-dianisidine~ and 10~1 90mM hydrogen peroxide were added and
the mixture allowed to react for 5mins, followed by washing;
in the second method, the same procedur2 was employed, except
that 2ml of buffer was added which did not contain the hydro
gen peroxide, but was 15mM in ~~D glucose'~ The reaction was
allowed to proceed ~or 30mins., followed by removing the
disk, washing and drying. In the third technique, the second
technique was repeated, except that 10~1 of a 3.9mg/ml
catalase solution was added.
In each case, there was a ste~dy progression of
increased darkness of the solid surface in going from the
stock solution of 90~g/ml of 03-carboxymethylmorphine through
1:5 serial dilutions to a final amount of 1.6xlO 12 mole.
The midpoint was found to be 1.2xlO 10 mole or about 40ng of
~5 0 -carboxymethylmorphine.
A sesond series of studies were performed using
morphine as an exemplary ligand. I'his study involved dif-
ferent sample fluids which would provide varying backgrounds
when performing the assay. The reagents were prepared as
ollows.
Ex. 3. Protein Coupllng to Paper Filter
Disk-Morphine
In O.lM NaI04 was incubated l~.Scm of Whatman #2
paper for Shrs at RT. The paper was then incubated in lM
ethylene glycol for 20min followed by washing with 6Q of
deionized water. To the paper was then added a total of
1. 8ml of the appropriate protein solutions in 50mM borate,
3~
74
0.2M NaCl, pH8.6 and the paper contacted with the protein
solution for 2hrs at RT~ The following gives the composi~
tions of th~ protein solutions.
PROTEIN SOLUTION',
AbM G o 1 BSA
_m~ protein
(1) 4
(2) 1 1 3
(3) 0.~5 1 3.75
(4) 1 4
(5) 1 0.25 3.75
Absorbance per cm at 280nm
.
To the paper was then added 2ml 2mg/ml NaBH4 in the
same buffer and the mixture allowed to stand for lhr at E~T.
The paper was then washed with water and buffer, then im-
mersed in a solution of 5mg/ml BSA, 15% sucrose and removed
and lyophilized.
For US2 in assays, 3/8" disks were punched and the
disks incubated in urine for 7min at RT, where the urine h~d
either no morphin~ or 100ng/ml morphine. The disks were then
transferred to lml of developer solution: 0.1mg/ml 4-Cl-l-
naphthol, 2mg/ml BSA, 50mM glucose, 0.1M PO4, pH7.0, 0.2M
NaCl and 0.1mg/ml o-dianisidine. To the 601ution was then
added 4~1 HRP-M (20~g/ml) and the mixture allowed to stand
for 30min at RT and the tests repeated with 15~1 HRP-M and a
reaction time of 60min.
In both cases ~he presence of the morphine was
clearly detectable for (1) and (4), with less difference with
the o~her samples. Thus, the assay is able to detect minute
amounts of morphine in the complex proteinaceous urine
mixture.
The next study was to determine whether morphine
could be detected in milk. The above procedure was repeated
employing lml raw whole milk with and without 100ng/ml
morphine. The procedure was varied by employing 100~1 oE
2~g/ml ~P-M and 10~1 of 3.9mg/ml catalase and incubating for
60min at RT with a developer solution of the following com-
position: ~OmM bicine, p~8.0, 200mM KCl, ~mg/ml BSA, 50mM
~-D-glucose and O.lmg/ml 4-Cl-l-naphthol. The diference
between the samples with and without morphine was clearly
detectable using disks prepared employing 1:1 of the AbM:GO
solution~ (see Table IV).
In -the nex~ study, -the use of a solid surface
conjugated with a mip W2S employed for the determination of
HIgG. In 0.5ml buffer containing 20~1 of an appropriate HIgG
concentration were incubated Smm paper disks (~bHIgGGO) for
3hrs at room temperature. The supernatant was removed, the
disks washed, and O.Sml buffer added plus 50~1 o a 13.8~g/ml
solution of AbHIg (DAKO). The mixture was then incubated
for 3hrs at room temperature followed by the addition of lml
of lOOmM phosphate, 200mM KCl, 50mM glucose and 0.lmg/ml
o-dianisidine. Afker 30mins at room temperature, the disks
were removed and washed, demonstrating a clear progression in
the color of the disks in going from 0.16 -to 20~g of HIgG.
E~. 4. THC-HRP Conjugate
Into a reaction flask was introduced O.l9ml of a
0.04M solution of the NHS ester of O~carboxymethyl oxime of
7,9,12-hexahydro-6,6-dimethyl-g-oxo-3-pentyldibenzo[b,d]
pyran~l-ol in DMF, 0.28ml ~RP (1.5mg), O.lml lM Na2C03,
p~9.5, and 0.3ml H20 and the mixture stirred o~ernight.
After centrifuging to remove insoluble material, the
supernatant was dialyzed against O.lM NaHCO3, 0.5M NaCl (4Q~.
The residue was chromatographed on a 20~1.5cm Sephadex G50
column in 50mM tris, pH7.6 J O.2ml and the void volume peak
isolated, ~3ml, 0.26mg/ml.
~. 5. Protein Couplin~ to Paper Filter
Dlsk-THC
The following protein solutions in 50mM borate,
pH8.5, 0.2M KCl were employed: antitetrahydrocannabinol,
IgG, ~3mg/ml; glucose oxidase, 18A2~0/ml.
Paper di~ks (Whatman ~1, 9cm~ were activated in
O.lM NaI04 for 4hr at RT followed by washing with ~3Q H2O.
To an activated disk was added 2.5ml of a protein solution
*Whatman is a trademark.
;
~: :
~3~
76
containing 3.83A280/cm glucose oxidase and 0.75mg of antisera
for tetrahydrocannabinol and the mixture allowed to react for
lhr at RT followed by the addition of 0~5ml of a 4mg/ml NaBH4
solution and the reaction mixture allowed to stand for 1.5hr
at RT, turning the disk every 20min. The d:isk was then
washed with 300ml 0.5~ NaCl, H2O (2x) and stored moist at 4.
In order to demonstrate the subject method for THC,
disks (~6mm~ were employed with lml urine spiked with varying
concentrations of THC. The urine sample was contacted with
the disk for lOmin at RT and the disk then transferred to a
developer solution containing 10~1 of a 1/100 dilution of the
above THC-E~P in lml 50mM glucose, 50mM barbitol acetate
buffer, pH7.6, O.lmg/ml 4-Cl-1-naphthol and r`action allowed
to proceed at RT for lhr. At the end o-~ that term the disk
in the urine containing 4.7ng/ml THC could be clearly distin-
guished from the nega-tive urine sample.
In accordance with the subject invention, a simple
sensitive technique is provided for determining analytes at
extremely low concentrations and providing for a relatively
permanent record of the result. The subject technigue allows
for assays which can be carried out without highly trained
personnel. Depending upon the rate at which the members of
the immunological pair bind, various incubation times may be
required, while development of the signal can be performed
over relatively short times. Furthermore, the samplès can be
used neat or with only minor dilution, so as to enhance the
rate of binding of the members of the immunological pair to
the solid surface.
The subject method provides for qualitative and
quantitative determination of haptens, antigens and recep-
tors, where standards can be performed to rela:te signal to
concentration. Visual observation of the solid surface may
be sufficient for qualitative or semiquantitative determina-
tions, while instrumentation can be employed to enhance the
~uantitative nature of the result. A substantial variety of
techniques may be employed to insure differentiation between
the signal generator produced at ~he surface and any signal
generator produced in the bulk solution. Thus, the signal
77
gene.rated at -the surface can be directly related to the
amount of analyte in the medium.
The subject method differs from prior art methods
in providing a method for deter~ining extremely low concen
trations of analytes by a simple protocol with a minimum
number of steps and reagent formulations. Furthermore, the
subject method involves a competition for binding sites or a
cooperation between binding sites of mips to have a catalyst
bind to a surface to provide a signal generating compound
associated with the surface. This is achieved without
requiring separation between the catalyst bound to the sur-
face and the catalyst in solution.
Since the use of the s~r~ace as a "dip stick" for
measuring analytes can be directed to use by non-technical
people--even for use in the home -it is important th~t the
method have as few indi.vidual steps as possible, be relative-
ly foolproof, particularly by allowing for a contxol which
can be carried out under substantially identical conditions,
and have as few measurements as possible. The subject inven-
tion fulfills these goals to a substantial degree.
Although the foregoing invention has been describedin some detail by way of illustration and example for pur-
poses of clarity of understanding, it will be obvious that
certain changes and modifications may be practiced within the
scope o~ the appended claims.
1 , ~
:, :
:,
,
